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In the United States 100 million people live with pain and must negotiate complicated 
clinical decisions that lead to a variety of treatments to control pain, some of which are 
effective and some that are not. Social identity theory and attribution theory guided the 
development of the interview protocol and analysis plan. A qualitative study was 
conducted to explore the complex nature of living with chronic pain through the 
narratives of seventeen adults in chronic pain for at least 3 months. Structural and 
thematic approaches were used to analyze the data. The structural results revealed three 
groups of participants: those who were pain-free at the time of the study, those using non-
opioid medications to manage pain (over-the-counter or prescription), and those using 
opioid medications. The narratives of chronic pain revealed the shared experience of 
managing the unpredictable ebb and flow of pain daily. The results also exposed 
confrontational and stigmatizing experiences with doctors on issues including how to 
express the severity of pain and request opioid medications. Many participants reported 
undertreatment for pain. They also noted that anxiety increased pain. All participants 
experienced stigma associated with chronic pain from sources such as employers, family, 
and friends. The results suggest that (a) an ecological model is useful for understanding 
the barriers to pain relief that patients experience, and (b) chronic pain might be better 
treated as a separate disease instead of a symptom associated with an underlying 
condition. The results also pointed to opportunities for positive social change including 
advocating for greater consensus on the definition and treatment of chronic pain, and the 
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Chapter 1: Introduction to the Study 
Pain is the oldest and still the most common reason for seeking medical treatment 
(Ljungvall et al., 2020; Meldrum, 2003; Prunuske, 2014; Sinatra, 2010; van den Beuken-van 
Everdingen et al., 2016; Vargas-Schaffer, 2010). Research often uses the terms “pain” and 
“suffering” interchangeably (Chapman & Gavrin, 1999). The difference between these two 
terms is critical to the comprehensive understanding of pain. This study was focused on the 
experience of persistent, chronic pain, defined as pain that continues after treatment for 
longer than medical providers expect (Gatchel et al., 2014; Siddall & Cousins, 2004; Stones 
& Cole, 2014). The evidence for the existence of chronic pain is undeniable (Berry & Dahl; 
2000; Swan & Hamilton, 2016; Volkow & McLellan, 2016; Wailoo, 2104). This chapter 
summarizes the current knowledge and challenges in pain research, how this study addressed 
the gaps in that research, and why addressing these gaps was significant. I then review the 
research questions and the theories behind the framework of the study. I then consider how 
those theories supported the research questions. 
Background 
In the United States alone, 100 million people have lived with chronic pain (Ambrose 
& Golightly, 2015; Ljungvall et al., 2020; Peppin et al., 2015). The treatment of chronic pain, 
unlike other physical symptoms, has been fraught with political, economic, and social 
challenges (Clauw et al., 2019; Nagel, 2016; Treede et al., 2019; Wailoo, 2014). Treating 
chronic pain exceeded the costs of other common chronic conditions such as hypertension, 
heart disease, and diabetes (Clauw et al., 2019; Staton et al., 2007). The research estimated 




Richard, 2012). Yet, despite enormous efforts and expense, medicine needed the research on 
the patient's voice to develop a more human understanding of the experience of chronic pain 
(Nichols et al., 2020; Rajagopal, 2011). 
There were multiple ways to define chronic pain in the research (Bell & Salmon, 
2009; Calati et al., 2015; Garschagen et al., 2015; Heit, 2001; Stubbs, 2016; Werner et al., 
2004; Wong et al., 2015). In most studies, chronic pain was considered pain that lasts longer 
than 3 months (e.g., Clauw et al., 2019; Rivera et al., 2015). By any definition, chronic pain 
was a complicated phenomenon and difficult to measure objectively (Koyama et al., 2005; 
Littlejohn et al., 2019; Treede et al., 2019).  
There were two main views on treating chronic pain (Nijs et al., 2019; Treede et al., 
2019). The first was that chronic pain is a symptom (Dowell et al., 2016; Henry et al., 2015). 
The second was that chronic pain is a disease (Clauw et al., 2019; Engel, 2012). Henry et al. 
(2015) stated that treating chronic pain as a primary condition masked the pain and led to 
increased dosages in pain medications and long-term problems, including addiction. From 
this perspective, opioid medications should be titrated down and eliminated over time, 
regardless of whether the underlying, pain-producing conditions had been resolved (Dowell 
et al., 2016). Collectively these researchers suggested that treating noncancerous pain as the 
primary goal risked iatrogenic addiction. In this view, the problem was primarily due to over-
prescribed pain medications (Dowell et al., 2016). Such research advised limiting or 
eschewing opioid pain medications, even when the patient complained of pain. It also 




Other researchers felt the basis of pain treatment should focus on quality-of-life 
considerations, not just medication types or dosages (Lynch, 2016; Melzack, 1990; Nijs et 
al., 2019; Treede et al., 2019). In this perspective, doctors administered pain medications at 
an effective dose to manage pain for as long as necessary. This control needed to be achieved 
by whatever means necessary, including the use of opioids (Gourlay et al., 2005; Kumar et 
al., 2015; Rajagopal, 2011; Treede et al., 2019).  
A frequent topic of controversy in the history of pain treatment was the need to 
confront quality-of-life factors and eliminate needless pain (Nijs et al., 2019). The latest 
iteration started in the medical community with cancer pain (Katz & Rosenbloom, 2015; 
Melzack, 1990). Later research supported the idea that pain control should be a primary goal 
(Bennett et al., 2019; Gatchel et al., 2014; Katz & Rosenbloom, 2015). However, many 
researchers took issue with the need to control pain as the primary goal in noncancerous, 
chronic pain (Bhamb et al., 2006; Chaparro et al., 2014; Compton & Volkow, 2006; Henry et 
al., 2015; Moseley & Butler, 2015).  
The epidemiological trend documenting the rise in opiate addiction has further 
complicated clinical decisions on pain control and polarized the debate (Peppin et al., 2015). 
The Centers for Disease Control and Prevention (CDC, 2015) reported that, from 1999 to 
2014, opioid addiction increased, which caused 160,000 deaths. The CDC report also 
estimated that there were 1.9 million people who abused or became dependent on opioids in 
2013. One theory was the over-prescription of opioid medications caused the rise in opioid 




Other research suggested prescribers may not be the primary cause of this increased 
addiction (Finnerup et al., 2015). Sullivan and Levin (2016) stated that more pain-producing 
conditions became evident as the number of baby boomers with chronic pain conditions 
increased as the country aged. The authors also noted that this population might have brought 
a tendency to be more open to the use of medications for pain control. Also, there was little 
evidence that reducing addictive pain medications would lead to better long-term pain 
management (Finnerup et al., 2015). Long-term pain management might require a 
personalized pain genotype, the identification of which needed more progress in neurological 
research (Bruehl et al., 2015). 
Staton et al. (2007) stated that doctors consistently underestimated pain levels among 
patients who sought treatment and complained of pain. The authors found these differences 
in perceptions were more pronounced when the patients were from an ethnic minority. Even 
when the patients participated in detailed questions about their pain, the goal appeared to 
persuade patients to follow medical advice (de C Williams, 2016; Moseley & Butler, 2015; 
Zanini et al., 2016).  
Stigmatizing systemic, social, and self-shaming judgments complicated pain 
treatments and undermined adequate control (Monsivais, 2013). Feelings of stigma were 
present in any disabling, chronic illness, including chronic pain (Jackson, 2005). Pain 
research often reported stigmatization feelings of chronic pain sufferers (Breivik et al., 2006; 
de C. Williams, 2016; Slade et al., 2009; Wilbers, 2015). This stigmatization sometimes 




Research on treating pain as a symptom versus pain as a disease created conflicting 
recommendations on medical treatments (Peppin et al., 2015). These research studies noted a 
possible increase in systemic stigma from the medical community and society in general 
(Bennett et al., 2019; Breivik et al., 2006; de C. Williams, 2016; Slade et al., 2009; Wilbers, 
2015). Other researchers suggested that the voice of patients was not appreciated (Rajagopal, 
2011; Tsao, 2012). More information regarding a chronic pain patient's experience could 
better illuminate ways to understand and treat the condition (Bury, 2001; Thomas, 2010). A 
narrative approach might address this research gap (Rajagopal, 2011). Webster and Harden 
(2013) thought pain was a qualitative experience. They and other researchers recommended 
narrative analysis as a possible means of rehumanizing the understanding of chronic illness 
(Bury, 2001; Rajagopal, 2011; Thomas, 2010).  
Problem Statement 
The persistence of chronic pain changes a person’s life and leads to comorbid events, 
including loss of work, depression, lower quality of life, isolation, and higher medical costs. 
(Von Korff et al., 2016). There is a lack of consensus on whether these aspects of chronic 
pain constitute a separate disease that requires its own course of treatment (e,g., Clauw et al., 
2019), or if the search for pain's underlying mechanisms should be the primary goal (Vardeh 
et al., 2016). Further, since pain cannot be objectively measured, the treatment of pain is 
based on self-report and the judgement of medical providers (Bourke, 2014). Often pain is 
considered a symptom of an underlying problem (Robbins, 2017). Accordingly, treatment is 
focused on diagnosing and treating the underlying problem and not concentrating on 




the voice of the patients in chronic pain (Rajagopal, 2011; Tsao, 2012). Some research has 
tried to address this gap using surveys and focus groups (e.g., Wong et al., 2015).  
Researchers are calling for more in-depth understandings from the patients’ perspectives. In 
this study I used narrative research to allow the participants to tell the story of their chronic 
pain experience in their own words. These stories explore the barriers to the adequate 
treatment of pain and how pain treatment can be improved. 
Purpose 
The purpose of this study was to explore the complex nature of pain through the 
narratives of participants who experienced chronic pain. The goal was to collect the stories of 
chronic pain treatment-seeking, pain relief, and stigma in pain patients. The plan was that 
these narratives would contribute to a deeper understanding of how pain might be better 
managed whenever possible. 
Research Questions 
This study addressed the following research questions and subquestions to draw 
closure on the identified gap in the literature: 
RQ1: What were the narratives of managing chronic pain for patients? 
SQ1a: How did these participants describe their experience of access to 
treatment? 
SQ1b: How did these participants describe their experience with the pain 
management process? 
RQ2: What was the meaning of stigma for these participants who used or believed 




SQ2a: How was stigma experienced in the treatment process? 
SQ2b: How was stigma experienced with family and other social supports? 
Framework 
One theoretical framework of this study was social identity theory (Dumont & Louw, 
2007). This theory posited social roles could take many forms depending on the perceptions 
of the individuals within a group (Trepte, 2006). Monsivais (2013) stated that individuals 
with chronic pain formed their identity within a group according to how openly they 
expressed their chronic pain feelings. With more severe pain, the author concluded chronic 
pain was difficult to hide. The result might be a change in social roles imposed by the pain 
condition. 
The change in social roles because of chronic pain invoked another theoretical 
construct, stigmatization. Some researchers suggested that stigma might result from a 
changed social role (Jackson, 2005). Much of the research documented the co-occurrence of 
chronic pain and stigma (de C Williams, 2016; Monsivais, 2013; Slade et al., 2009; Waugh et 
al., 2014; Werner et al., 2004). Stigma was evident in multiple pain studies, even when 
stigma was not the focus of the research questions (Breivik et al., 2006; Slade et al., 2009; 
Sturgeon & Zautra, 2016). The emotional impact of stigma lowered the ability to manage 
pain (Waugh et al., 2014). There was also evidence of stigma in situations where there was 
no observable bias (Monsivais, 2013). 
A second theoretical framework came from the attribution theory. Attribution theory 
deals with how people create causal explanations in the absence of objective evidence 




gave a more socially acceptable answer to their doctors (Augoustinos et al., 2014). Also, 
because there is no objective measure of pain except by self-report, this theory was useful in 
understanding why patients and doctors disagree about the severity and causes of chronic 
pain (Staton et al., 2007). Attribution theory also helped explain when the substitution of a 
causal explanation, imposed without the conscious awareness, created a false memory 
(Reyna et al., 2016). Finally, attribution theory helped design questions for the structured 
interview so that the inquiries did not bias the outcome (Douglass et al., 2013). 
Nature of the Study 
For this study I used narrative research to explore the experience of people who live 
with chronic pain. Jovchelovitch and Bauer (2000) stated that narrative research was a well-
recognized method for documenting shared cultural experiences, particularly illness and 
persistent pain experiences. Both the subject and the experimenter were active participants in 
creating a credible account with a beginning, middle, and end (Riessman, 2008). Surveys and 
case studies removed data from their original contextual relationships and placed them in 
another context, thus changing their meaning (Maxwell, 2013). Putting the data back into its 
original contextual relationship is an excellent way to maintain and fully understand the 
unique experience of chronic pain (Rajagopal, 2011). 
For this qualitative, narrative study I interviewed 17 participants with chronic pain 
with one interview per participant. The participants were people who responded positively to 
an invitation from a referral source or expressed an interest in participation after hearing 
about the study's exitance. Each participant signed a written consent before beginning the 




own words. The data was recorded, transcribed, and then analyzed for common elements. 
Analysis of the themes for either supporting or disconfirming the research questions 
followed. These analyses included hand-coding, structural analyses, and computer 
assisted/aided qualitative data analysis software (MAXQDA™). Participants experiencing 
chronic pain often shared sensitive topics. Attempts to earn the participant's trust, assure 
confidentiality, and develop a nonjudgmental, empathic connection were high priorities. 
To facilitate trustworthiness, the recommendations of experts in qualitative research 
guided the creation of the research questions and subquestions (Noyes et al., 2017; Riessman, 
2008; Saldaña, 2016; Shenton, 2004). The thematic analysis approach uses structural 
analysis, theme identification, member checking, and computer software coding programs 
(Riessman, 2008; Saillard, 2011). 
Definitions 
The following definitions were terms used in this study: 
Abuse of pain medications: This term defines one of the ontologically independent 
effects of pain medications in the treatment of chronic pain. This term describes when a 
person takes a pain medication that a doctor did not prescribe, is prescribed for another 
person, or when a person takes over-the-counter (OTC) drugs beyond the recommended dose 
without a doctor’s advice (Vowles et al., 2015).  
Adverse drug events: The term applies to all possible unfavorable pain medication 
outcomes, including side-effects, tolerance, drug escalation, and addiction. (Chapman et al., 




Addiction: This term is one of three ontologically independent expressions used to 
define the adverse effects of pain medications. Here it refers to the continued use of a pain 
medication despite a lack of relief, apparent harm, or a craving for the recreational effects. 
(Vowles et al., 2015). 
Attribution theory: The theory states that a person creates an explanation in the 
absence of sufficient objective evidence to confirm the conclusion. This term explains how 
doctors come to erroneous conclusions on treating pain based on their experiences (Kelley, 
1973). 
Confirmation bias: This occurs when a person overestimates the effects of a given 
treatment or intervention in complicated situations or treatments. (Stubbs, 2016). 
Chronic overlapping pain: With chronic overlapping pain, multiple underlying 
conditions contribute to the source of chronic pain, making the diagnosis, treatment, and pain 
relief more complicated (Fillingim et al., 2020; Littlejohn & Guymer, 2019).  
Drug escalation: This occurs when the dosage of a drug increases more quickly than 
recommended by the standard practice to relieve pain (Henry et al., 2015). 
Dependence on pain medications: This term is one of three ontologically independent 
expressions used to define the adverse effects of pain medications. This term applies when 
the titration or lowering of a pain medication increases severe pain or the inability to manage 
pain effectively. (Vowles et al., 2015). 
Epidemic: The term applied to any medical problem that outstrips existing medical or 
other treatment resources (Barth et al., 2017; Dowell et al., 2016; Huffman et al., 2015; 




Face Pain Rating Scale: This scale is the most common method of self-reporting 
pain. It is a 0-10, Likert-scale with Rating 0 (no pain) to Rating 10 (the most pain possible). 
Over each rating are hand-drawn faces that represent the increasing severity of pain (Swan & 
Hamilton, 2016). 
Gatekeeper: In medicine, physicians have a dual role of healer and gatekeeper.  In 
their gatekeeper role, they determine access to treatment and medical needs. (Carlsen & 
Nyborg, 2017). 
Iatrogenic addiction: This term represents an addiction that results from the over-
prescription of pain medications (Dowell et al., 2016; Higgins et. al., 2018). 
Joint Commission: Formerly called the Joint Commission on Accreditation of Health 
Organizations (JCAHO). The Joint Commission is an accreditor of hospitals and other health 
care providers. They also are deeply involved in setting standards for pain management 
(Berry & Dahl, 2000). 
Narrative research: This term refers to qualitative research that uses the participant's 
entire story and breaks the data into themes. After that, the analysis identifies the common 
themes between participants (Jovchelovitch & Bauer, 2000; Maxwell, 2013; Rajagopal, 
2011).  
Opioid: Any medication based on morphine or designed to give the same relief to 
pain as morphine and has proven to lead to addiction in some people (CDC, 2015). 
Pain: There was no commonly accepted definition for this term. A lengthy discussion 
of the definitions of pain is in Chapter 2. The most common meaning: Doctors should allow 




Pain model: In the absence of an objective measure or theory of pain, models can 
organize various conceptions of pain and pain treatment modalities (Engel, 2012). 
Pain event: Because the definition of pain can vary from study to study, this term was 
one way to describe a complaint of pain without accepting any given interpretation of pain 
(Bourke, 2014). 
Pain relief: The term is used when the patient no longer complains of pain. It can also 
mean a 50% reduction in pain as defined by the patient (Finnerup et al., 2015). 
Pain treatment: This refers to any intervention used to relieve pain, regardless of its 
effectiveness (Wailoo, 2014). 
Pain tolerance: This term refers to when a patient self-reports a lower level of pain 
than expected given the cause (Irving, 1988).  
Person-centered care: The term used when treatment included patient values, 
preferences, expectations, and social circumstances (Brummel‐Smith et al., 2016). In areas of 
long-term treatment, this term is more widely accepted. (Wade & Halligan, 2017). 
Propensity scores: This is a method to explore differences in groups with 
observational or nonrandomly selected data. A propensity score creates a probability that a 
subject will be in one group or another. This evaluation allows researchers to evaluate 
whether differences are a result of treatment effects (Luellen et al., 2005). 
Pseudoaddiction: The term is used to identify when addictive behavior disappears 
after reported pain is relieved. (Bell & Salmon, 2009).  
Publication bias: The term is used when outside influences affect the number and 




Quality of life: This term is used when treatment outcomes should consider overall 
well-being and pain relief in addition to medication types and dosages (Lynch, 2016; 
Melzack, 1990). 
Qualitative trustworthiness: Trustworthiness is a term used by qualitative researchers 
instead of validity. This term differentiates qualitative study terms from quantitative terms 
(Roulston & Shelton, 2015). 
Referral source: This is a strategy that prevents a researcher from purposefully 
choosing participants in a qualitative study and potentially introducing biases in the research 
study. By putting a referral source between the participants and the researcher, participants 
would more likely reflect the actual topic under study (McLeod, 2017). 
Saturation: In narrative studies, saturation occurs when the same data repeats in 
interviews and no new insights are likely to be discovered. Saturation usually leads to 
terminating the search for participants (Boddy, 2016; Francis et al., 2010; Mason, 2010). 
Social identity theory: Social identity theorists study how a self-concept evolves and 
internalizes. This evolution comes from the need to develop and preserve a positive self-
image when interacting with a social group (Abrams & Hogg, 1988). 
Stakeholder: Anyone affected by the pain strategies and treatments of the patient 
could be considered part of this group. It includes patients, providers, government officials, 
pharmaceutical companies, family members, researchers, and affected professional agencies 
(Boswell, & Giordano, 2009). 
Stigma: This label describes when repeated experiences of negative bias spoil the 




Suffering: The taxonomic category ranks above physical pain and includes all types of 
human anguish, not just pain that arises from disease (Nagel, 2016). 
Triangulation: This is a qualitative research strategy where a researcher collects data 
from different sources. This study did not use this technique (Shenton, 2004). 
Undertreatment: This is a label used when a provided treatment results in inadequate 
pain relief and allows unnecessary pain (Peppin et al., 2015). 
World Health Organization (WHO) Algorithm: The WHO suggests an algorithm for a 
step-by-step approach to pain treatment. Sometimes this approach results in prescribing 
opioids (Ventafridda et al., 1987; WHO, 2017). 
Assumptions 
I made the following assumptions with this study: 
 I assumed a person can better understand the experience of pain by interviewing 
people who suffer from chronic pain. 
 I assumed that despite individual differences, there are some similar situations for 
people in chronic pain, the exploration of which may help optimize pain 
treatment.  
 I assumed stigma can be a consequence of bias that people with chronic pain 
experience, and that this experience is likely in social and medical settings. 
 I assumed that narrative medicine research can contribute to improving the 





Scope and Delimitations  
The following boundaries were inherent in this study: 
 While there are similar experiences to chronic pain, the results from this study 
may not apply to people in acute pain. The short-term duration of acute pain 
sometimes allows for the enduring of pain until relief comes via healing. Acute 
pain relief within the period that medical providers expect is not part of the scope 
of this study. 
 The nature of purposeful sampling (where the qualitative goal is to seek 
participants who share experiences) does not allow for inference to populations 
not included in the study. 
 Due to the locale where I captured the data, the data might have been shaped, at 
least in part, by the lack of available local, specialized treatments. This concern 
was addressed in the results. 
Limitations 
The following were limitations to the study: 
 This study depended entirely on the reported experience of the participant. There 
was no attempt to use information from the participant's medical providers, 
friends, or family. The study did not use triangulation in any other form to verify 
the reported experience of the participant. 
 While not as easily observable in situations where pain can be lessened or better 




conclusions of this study might apply to cases where experienced pain is not as 
severe. Identifying those situations, however, was not a goal of this study. 
 Because pain ebbs and flows, a report of pain at the interview may not be 
consistent with another interview taken later from the same participant. In this 
study I aimed to find similar experiences between pain participants, not to 
understand the longitudinal sequala of future pain experiences. 
Significance 
Considerable literature has documented the propensity to undertreat chronic pain due 
to: (a) fear of addiction or misuse, (b) fear of adverse effects, (c) lack of diagnostic criteria, 
and (d) lack of training (Bell & Salmon, 2009; Bhamb et al., 2006; Chapman et al., 2010; 
Gourlay et al., 2005; Peppin et al., 2015;). Rajagopal (2011) stated that the patient's voice 
was missing from the treatment debate in all cases. The author further noted that little 
research examined the patient’s narrative regarding pain relief and the effects of stigma. Such 
research could deepen the field’s understanding of (a) the consequences of medical decisions 
to restrict access to pain medications, and (b) the social effects of long-term pain on 
treatment outcomes (Tsao, 2012).  
One goal of this study was to contribute to professional practice by improving 
compassionate care for patients in a medically appropriate way. Another goal was that this 
study's results would add to the growing body of knowledge that contributes to a deeper 




Summary and Transition 
Unlike other physical symptoms, chronic pain treatment is fraught with multiple 
challenges, including high costs. Because there is no objective measure of pain, our measures 
of pain are usually documented by self-report. Despite centuries of research, there are 
competing theories as to the characteristics and treatment of pain. The rise in opiate addiction 
has further complicated clinical decisions on pain control and polarized the debate. Stigma 
might complicate pain treatments and prolong adequate control.  
As a result, more research was necessary for people who suffer from chronic pain. 
Such research should deepen our understanding of their pain experiences. Pain research also 
suggested this understanding might be essential to provide optimal care and reduce 
unnecessary pain.  
This study's theoretical frameworks included social identity theory and attribution 
theory, with the construct of stigma. For the study I had planned to interview 15 participants 
with chronic pain, but in the end I interviewed 17 participants for the study. They came from 
people who responded positively to an invitation from a referral source or volunteered after 
hearing about the study. All responses were recorded and analyzed using techniques 
consistent with narrative analysis. 
Chapter 2 begins with a historical context of the perception of pain. It includes how 
chronic pain is defined and measured in healthcare. The published literature indicates a lack 
of consensus on pain measurement, making prevalence estimates difficult. The next section 
focuses on the treatment and undertreatment of pain, the latter fueled by fears of growing 




chronic pain and have used opiates for pain relief. I present the theoretical frameworks of 
social identity theory and attribution theory and describe them in relation to the participants’ 





Chapter 2: Literature Review 
There exists a large body of research on pain and the treatment of pain (Bennett et al., 
2019; Clauw et al., 2019; Littlejohn et al., 2019; Ljungvall et al., 2020; Nichols et al., 2020; 
Nijs et al., 2019; O’Keeffe et al., 2016; Singh et al., 2016; Schuchat et al., 2017; Tighe et al., 
2017; Treede et al., 2019; van den Beuken-van Everdingen et al. 2016; Walther-Larsen et al., 
2017). However, there remained a lack of consensus on the definition, diagnosis, and 
treatment of chronic pain (Bennett et al., 2019; Finnerup et al., 2015; Gourlay et al., 2005; 
Nijs et al., 2019; Wailoo, 2014). An in-depth review of the literature revealed that there was 
little research on how individuals with chronic pain struggled with treatment options, got 
relief from pain, and dealt with the stigma associated with the use of prescription 
medications, particularly opioid medications. It also indicated a possible need to develop 
more research on the chronic pain treatment experience to illuminate better ways to 
understand and treat the condition. 
Literature Search Strategy 
I used the following databases to search the literature on pain, pain relief, and its 
outcomes: (a) EBSCO, (b) PsycINFO. (c) PubMed, (d) SAGE Collections, and (e) Science 
Direct. The major search terms included addiction, pain, pain models, pain treatment, pain 
relief, and stigma. I also searched two terms associated with qualitative research: bias and 
narrative research.  
Due to the complex nature of pain, I used other terms within each major search 
category to develop a more complete picture of the nature of pain. For addiction, minor 




and the War on Drugs. Pain search terms also included acute pain, breakthrough pain, 
cancer pain, chronic pain, costs of pain, depression, neuropathic pain, pain assessment, 
persistent pain, suffering, and suicide. Pain model terms included searches for biomedical 
model and biopsychosocial model. Pain treatment searches sometimes included alternative 
therapies, chronic pain treatments, efficacy, Joint Commission, marijuana, opioids, 
treatment satisfaction, palliative care, quality of life, side effects, survival analysis, treatment 
compliance, and universal precautions. Pain relief was searched with inadequate pain 
management, opioid psychopharmacy, outcome measurement, palliative care, 
pseudoaddiction, and undertreatment. Finally, stigma searches also sometimes included 
disbelief, discrimination, health care encounters, and patient-centered care.  
In searching for research bias, I used terms such as confirmation bias, false memories, 
hindsight bias, response bias, prejudice, and publication bias. Narrative research included 
other search terms such as client satisfaction, illness narratives, qualitative research, and 
qualitative synthesis. 
Given the multiple perspectives on pain and the various interests of stakeholders in 
the treatment of pain, complex searches for this study were inevitable. Whenever possible, 
these searches used the most recent citations. Many qualitative and pain treatment 
perspectives, however, tended to collect in the more distant past. As values changed, attitudes 
towards chronic pain changed, and this affected the research literature. As I will posit, there 




A Short History of Pain 
Meldrum (2003), in a capsule history of pain management, stated that the philosophy 
of pain dated back at least to the Judeo-Christian religion. The author noted that the story of 
Job and the Passion of Christ suggested that chronic pain was almost necessary for moral 
behavior. Meldrum added that early utilitarian philosophers used pain and pleasure as 
opposing measures to determine good. The author added that doctors in the 17th century 
viewed chronic pain as a measure of resilience and potential recovery from illness. Meldrum 
stated that these views started to change with the widespread introduction of opium, 
beginning in 1680. The author pointed to the later introduction of morphine, an opium 
derivative, marketed under Heroin, contributing to this change.  
Meldrum (2003) suggested the new use of anesthesia during surgery as another 
influence on the medical view of pain. During this period, when the underlying cause of pain 
could not be determined, the liberal use of medications to minimize pain was considered 
standard practice (Bourke, 2014; Meldrum, 2003; Wailoo, 2014). Meldrum further stated that 
the pendulum began to swing in the opposite direction in the early 1900s, when addiction, 
psychological treatments of pain, and the development of theories that chronic pain rewired 
the nervous system appeared. Meldrum added that, during this period, a wide variety of 
alternatives to narcotic medications were developed, with limited success in the case of 
chronic pain. After World War II, the suffering of soldiers returning home from the war with 
refractory, chronic pain conditions began to change medical opinions back to minimizing 




Wailoo (2014) stated that pain treatment in the next 6 decades was fraught with 
political, economic, and social challenges. According to the author, since World War II, the 
societal view of pain could be divided between politically conservative and liberal 
viewpoints. In the conservative view, pain tolerance was a transformative experience that 
helped patients become more vigorous and motivated to overcome any disability. Direct 
treatment of pain, in this view, inevitably led to the overuse of medications, increased 
government involvement, creeping socialism, and dependency. Wailoo further added, in the 
liberal view, chronic pain was a significant obstacle to happiness. The author noted that this 
view posited pain relief as essential to developing compassion, a sense of community, and a 
quality life. Due to these opposing political views, Wailoo concluded that necessary suffering 
and unnecessary pain were often not defined by doctors treating patients. Instead, the author 
stated professional agencies, governmental laws, and the courts usually established these 
standards.  
Bourke (2014), in a book on the history of pain perception, stated that pain 
historically was a shared experience based on individual and cultural attitudes of what 
Bourke called a “pain event” (p. 20). Other pain research literature also used adverse drug 
event terminology when describing pain medication problems (Chapman et al., 2010; 
Gourlay et al., 2005; Heit, 2001; Vowles et al., 2015). Bourke went on to say that when a 
person was in pain, there was no way of objectively measuring the experience except by what 
the person in pain reported and how an observer interpreted that report. The author concluded 




Since 2000, the need to aggressively assess and treat pain again came into question 
(CDC, 2015; Dowell et al., 2016). In an editorial, Robbins (2017) suggested that the 
treatment of pain as the fifth vital sign, even when a patient did not complain of pain, led to 
the overuse of pain medications. The author suggested that the increase in fatal opioid 
addictions coincided with the same period as overzealous pain assessments. Robbins 
questioned whether there was undertreatment in more than 10% of people who complain of 
postoperative pain. While the author admitted that the increased emphasis on pain 
assessments and the increase in opioid addiction might be a coincidence, the use of pain 
scales in all medical situations has come into question. The American Medical Association 
(Anson, 2016) and the American Academy of Family Physicians (Lowes, 2016) dropped the 
advice to use pain scales in routine medical assessments.  
The controversy on pain, its costs, and its causes continued to date (Clauw et al., 
2019; Finnerup et al., 2015). The National Pain Strategy, a National Institute of Health study 
on pain, concluded that ongoing research on chronic pain could provide (a) insights on 
prevention, (b) the best ways to educate patients and physicians, and (c) better interventions 
for chronic pain (Deacon, 2013; Von Korff et al., 2016). Yet, the complexity of treating 
chronic pain and the continuing lack of consensus on even the definition or assessment of 
chronic pain seemed to make that goal elusive (Bruehl et al., 2015). 
Defining and Assessing Pain 
The dilemmas of understanding pain begin with the challenges of defining and 
assessing pain (Bourke, 2014; Wailoo, 2104). Often, pain definitions overlapped, 




was an alarm signaling that a biological system is malfunctioning (Haylock, 2002). Another 
was that it is an objectionable sensory experience, with emotional aspects related to tissue 
damage or the possibility of tissue damage (Driscoll & Kerns, 2016). Tighe et al. (2015) 
compared chronic pain to hunger and nausea, which are medical problems with multiple 
causes manifesting with similar symptoms.  
Julien et al. (2014), in a book on psychopharmacology, stated that pain has two broad 
categories. These categories included: (a) nociceptor pain, where observable tissue damage 
was evident; and (b) neuropathic pain, believed to be caused by a nervous system 
dysfunction. When pain disappeared within the expected healing time for the observed tissue 
damage or diagnosis, doctors defined nociceptor pain as acute pain (Gatchel et al., 2014). On 
the other hand, when chronic pain persisted, doctors labeled the pain neuropathic (Julien et 
al., 2014). To include pain where there was no observable biological cause, Brodal (2017) 
suggested that a reductionist definition of chronic pain focused on specific effects, such as 
pain scales, cannot fully comprehend a pain event. Instead, the author proposed a third 
general category of pain called homeostatic pain. In this definition, Brodal suggested the 
source of chronic pain was a perceived threat to internal hemostasis. The author further 
suggested that something triggered the pain alarm system, like an automotive theft alarm 
sounding in the dead of night, but the exact cause may be unknown. Further divisions of 





Acute Pain  
Doctors labeled pain from a surgical procedure, recent onset of an illness, or a 
traumatic injury as acute pain (Sinatra, 2010; Tighe et al., 2015). Qaseem et al. (2017), in an 
article on the treatment of back pain, defined acute pain as lasting less than four weeks and 
subacute pain as lasting between 4-12 weeks. If it lasted longer, depending on the diagnosis, 
it was considered chronic pain. 
Johnson (2005) discussed the differences between the two commonly used pain 
scales. The author stated that one used a scale without rating numbers (visual analog scale), 
and the other used a scale with rating numbers (numeric rating scale). Drawn faces were an 
early suggestion for measuring pain in children (Stuppy, 1998) and later added to the 
numeric pain scale (Flaherty, 2008). Swan and Hamilton (2016), in an instructional essay on 
pain assessment for advanced student nurses, stated that a face pain scale continued to assess 
the severity of acute pain. The authors further indicated that it has evolved into the 
commonly used pain scale because of its 0-10 ratings and illustrations of facial expressions. 
Swan and Hamilton further stated that, in this rating system, the lowest rating represented no 
pain, and the highest rating represented the most pain possible. The authors also noted that 
hand-drawn faces accompanied these numbers, ranging from a smiling face (Rating 0) to a 
frowning hand-drawn face (Rating 10).  
In addition to face drawings, a variety of numeric and visual rating scales assessed the 
intensity of chronic pain in children (Castarlenas et al., 2017). In addition to numeric pain 
scales, there were verbal rating scales where children had to pick out a phrase that best 




scale, a 10-centimeter line colored in increasingly deepened red shades to indicate pain 
intensity. The authors added that a child moved a marker over a line to indicate the severity 
of pain. 
Weissman et al. (2015) found physicians often had to rely on the report of caregivers 
when people with disabilities were in chronic pain and were unable to report pain symptoms 
reliably. At times the addition of a supplemental checklist facilitated direct observation. The 
authors added that doctors depended on this strategy for people with dementia. In older 
adults, particularly after a fall or a motor vehicle accident, the tendency to become sedentary, 
even when activity was low before the injury, tended to prolong their recovery (Platts-Mills 
et al., 2016). Kaufman and Baucom (2014) stated that ignoring these likely comorbid 
conditions prolonged recovery and called it diagnostic overshadowing.  
Meek (2015), in another clinical review on pain assessment for nurses, stated that a 
report of pain needed to be followed by more in-depth questions. The author further noted 
that acute pain assessment could use the mnemonic OLDCART: (a) onset of the pain; (b) 
location of pain in the body; (c) duration of pain; (d) characteristics of the pain (e.g., 
crushing, burning, stabbing, etc.); (e) aggregating factors of the pain (e.g., triggers, activities, 
body positions, events that make the pain worse); (f) relieving factors of the pain (e.g., cold 
compresses, heat, avoidance, and relaxation); and (g) temperature (e.g., cold skin, warm 
skin). Meek further stated that patient-centered care often required an expanded role for 
nurses, and these assessment skills were within their potential competencies. Several newly 
developed multimodal pain scales for assessing acute pain also existed but were not yet in 




Chronic Noncancerous Pain 
Chronic, non-cancerous pain had many definitions, making it very difficult to assess 
(Honey et al., 2016). One description was that it was a health disorder that had pervasive 
adverse effects on patients and their families (Garschagen et al., 2015; Von Korff et al., 
2016). Others described chronic pain as a disabling physical condition with several 
concomitant psychological disorders, including depression, loss of hope, a lack of motivation 
(Wong et al., 2015), and suicidal feelings (Calati et al., 2015; Stubbs, 2016). The negative 
impacts on employment, leisure, life goals, and other quality of life supports often appeared 
in reports of chronic pain (Werner et al., 2004; Von Korff et al., 2016). A fourth definition 
was that chronic pain differed from acute pain in that it lasted longer than expected to 
provide a protective function for the body to heal (Gatchel et al., 2014). The patient defined 
chronic pain by its location and severity as a fifth, older, but still widely accepted definition 
(Haylock, 2002; Newton et al., 2013). Finally, as stated above, in many studies, researchers 
defined chronic pain as pain that lasted longer than three months (Vallerand et al., 2015; Von 
Korff et al., 2016; Vowles et al., 2015). 
Chronic Regional Pain Syndrome 
Schneider et al. (2015) stated that Chronic Regional Pain Syndrome (CRPS) is a pain 
disorder that spreads from an injured site to affect a broader region of the body, often 
limiting itself to one area, such as a limb. While usually starting with a traumatic injury 
(Type I), the authors stated that the etiology and magnification of its broader pain effect was 
unclear, as was its sequela. Schneider added that, even when there was no observable injury 




skin color and temperature; (c) abnormal burning sensations, sweating, sometimes followed 
by chills; (d) edema; and (e) unusual changes in sensory-motor functioning. Carr et al. (2016) 
believed that CRPS was very complex to diagnose and treat and often resulted in severe pain. 
The authors stated that early diagnosis is essential to treatment, but the accurate diagnosis 
often was delayed because it was a diagnosis by exclusion. 
Chronic Pain Cancer Related 
Parala-Metz and Davis (2013) stated that cancer pain was more difficult to assess 
than acute pain. The authors posited its presentation varied according to: (a) multiple onsets; 
(b) varying durations; (c) multiple locations; (d) genetics; (e) medical history; (f) patient 
mood; (g) patient expectations; and (h) the culture of the patient. Parala-Metz and Davis 
further stated that cancer pain was usually classified as chronic pain because it often lasted 
longer than three months. Nonetheless, episodes of acute pain frequently flared up within the 
course of treatment. These flare-ups were called breakthrough pain (Portenoy et al., 1999; 
Winiarczyk & Knetki-Wróblewska, 2016). Other authors stated that doctors did not fully 
understand breakthrough cancer pain, making an effective diagnosis and treatment difficult 
(Bennett et al., 2019; Mercadante. 2018). Paice et al. (2017) suggested that one way to meet 
this challenge was to vary pain diagnoses by types of cancers. However, when the authors 
used only three types of cancers, they found that their criteria applied more generally would 
cause controversy. This realization led Paice to conclude that their goal of an evidence-based 




Chronic Overlapping Pain 
Fillingim et al. (2020) stated that chronic overlapping pain occurred when multiple 
sources created chronic pain. The authors noted that chronic overlapping pain was more 
likely to develop chronic pain's comorbid psychological effects. Fillingim studied various 
combinations of overlapping pain sources and found they all significantly impacted 
emotions, which increased overall pain. 
Persistent Acute or Chronic Pain 
This term became the general term for any pain that continued for longer than a 
medical provider expected (Gatchel et al., 2014; Siddall & Cousins, 2004; Stones & Cole, 
2014). Based on clinical experience, this expectation was usually classified by diagnosis and 
intervention (e.g., Kainu et al., 2016; Proud & Howard, 2016; Rutten et al., 2016). Higgins et 
al. (2018), in a meta-analysis, found that persistent acute pain challenged current medical 
resource allocations, but the research did not support the widespread incidents of iatrogenic 
opioid addiction. In a later chapter, I will discuss the relationship between persistent pain and 
addiction. 
In summary, pain, acute or chronic, was a condition that most people had 
experienced. Yet, the idiosyncratic nature of chronic pain (i.e., origins, time frame, and co-
occurring conditions) created challenges for researchers to converge on a single definition or 
assessment process. Complex pain symptoms defied precise diagnosis and assessment, 




Prevalence of Pain 
The difficulty of defining and diagnosing pain not only negatively affected the ability 
to determine an accurate prevalence of pain, but it also interfered with indirect 
epidemiological indicators used to understand the breadth, depth, and severity of a pain 
“epidemic” (Barth et al., 2017; Dowell et al., 2016; Higgins et al., 2018; Huffman et al., 
2015; Penders, 2013; Reuben et al., 2015; Volkow & McLellan, 2016; Vowles et al., 2015). 
As stated above, treating pain exceeded the costs of other common chronic conditions such 
as hypertension, heart disease, and diabetes (Moore et al., 2014; Staton et al., 2007). Chronic 
pain cost estimates ranged from $560 to $635 billion annually (Gaskin & Richard, 2012; 
Nahin, 2015). Since there was so much variability in the definition and assessment of pain, 
physicians used their clinical judgment to assess and treat pain (Bhamb et al., 2006). These 
varying clinical judgments affected estimates of pain prevalence (Paydar et al., 2016). To 
address these difficulties, pain studies researchers often limited their prevalence studies to 
subcategories of pain definitions and diagnoses. 
Acute Pain Prevalence 
The primary complaint in most emergency rooms was acute pain, encompassing 40% 
of the 100 million people who sought emergency care in a hospital each year (Ahmadi et al., 
2016; Sinatra, 2010; Stalnikowicz et al. 2005). Acute pain was also a concern in the 70 
million surgeries performed yearly in the United States (Tiege et al., 2015). One study on 
postoperative pain indicated: (a) 84% experienced pain five hours after abdominal surgery; 
(b) 92% experienced pain two days after surgery; and (c) 96% of post-surgical patients 




reported moderate-to-severe pain intensity two weeks after discharge (Sinatra, 2010). Lack of 
aggressive treatment of acute pain often sets the stage for preventing a host of later pain 
complications--including chronic pain, infection, and morbidity (Nagel, 2016). Tiege et al. 
(2015) suggested that, despite enormous research, acute pain was still not well understood. 
The resources were variable, and there was a need to go beyond relying solely on 
medications.  
Chronic Pain Prevalence 
By one estimate, in the U.S. alone, more than 100 million people live with chronic 
pain. Other estimates ranged from 14%-25% of the general population (Peppin et al., 2015; 
Von Korff et al., 2016). The Center for Disease Control estimated that 11.2% of the general 
adult population had some form of chronic pain (Dowell et al., 2016). In other countries, 
chronic pain estimates range up to 8% of the general population (Gilron et al., 2015). In 
patients over 65, chronic pain estimates range up to over 33% of the aging population 
(Molton & Terrill, 2014). In a worldwide meta-analysis, chronic pain prevalence increased 
steadily according to age group, going from 14.3% in young adults to 62% in adults over 75 
years old (Lynch, 2016).  
Cancer Pain Prevalence 
Patients with cancer experienced chronic pain 30%-45% of the time (Fujii-Lau, et al., 
2015; Vuong et al., 2016). In advanced cancer, the prevalence of pain rose to 75% (Haumann 
et al., 2017; Haylock, 2002). In a worldwide meta-analysis, van den Beuken-van Everdingen 
et al. (2016) stated that chronic pain in cancer patients was evident in approximately: (a) one-




treatments; and (c) two-thirds of the patients with advanced or terminal cancer. Overall, the 
authors further stated that more than one-third of cancer patients reported their pain as 
moderate to severe. Research showed that numerous factors affected the perception and 
sequela of chronic pain management in cancer treatment (Swan & Hamilton, 2016). These 
variabilities made developing a consensus on the assessment and treatment of chronic pain 
difficult (Von Korff et al., 2016). 
Chronic Regional Pain Syndrome Prevalence 
Schneider et al. (2015) found 50,000 new chronic regional pain syndrome (CRPS) 
cases each year, and a population estimated between 1.5-3.0 million people. Another estimate 
was the prevalence of CPRS-I (i.e., with injury) was 0.26 per thousand per year (de Mos et 
al., 2007; den Hollander et al., 2016). Ratti et al. (2015) stated the complexity of CRPS 
diagnosis made epidemiological estimates unreliable. The authors said that, while CRPS has 
had various labels over the past century, the prevalence was considered very rare. Ratti et al. 
(2015) concluded that, with better diagnoses, CRPS was secondary to multiple etiologies. 
These included: (a) fractures, (b) surgery, and (c) genetic predisposition. Yet, confusion 
continued in the literature. 
To differentiate chronic regional pain, widespread chronic pain, and fibromyalgia, 
Kim et al. (2012) defined chronic regional pain as existing in a particular area of the body 
and widespread chronic pain as pain over the entire body. The authors then further 
differentiated widespread chronic pain from fibromyalgia by looking for 11 out of 18 tender 
points, often seen in fibromyalgia. In a Korean hospital, the authors found chronic regional 




patients and fibromyalgia in 1.7% of the patients. As in chronic pain, CRPS was challenging 
to diagnose, treatments lacked consensus, and much more research was necessary to develop 
practical prevalence guidelines (Ratti et al., 2015). 
Persistent Pain Prevalence 
Estimates are that approximately one-third of the American population experienced 
pain at any given time (Driscoll & Kerns, 2016). In the most recent study on pain prevalence, 
Nahin (2015) extracted data from 2012 medical statistics, taken from 8,781 adults in 17 
categories of illnesses likely to produce pain. From that survey, the author estimated that, in 
America, 126 million patients (55%) were in some form of pain over the previous three 
months. Also, Nahin further estimated that 25.3 million (11.2%) were in daily pain, and 25.3 
million (10.3%) were in moderate to severe pain.  
In summary, the prevalence of pain was difficult to determine because chronic pain 
was difficult to define and assess. Depending on the type of pain, the underlying medical 
problem, and the population in question, pain prevalence estimates range from 8% to 45%, 
with vulnerable populations and complex pain ranging as high as 75% (Peppin et al., 2015; 
Singh et al., 2016; Von Korff et al., 2016). It was the most common complaint when people 
seek medical treatment (Meldrum, 2003; Prunuske, 2014; Sinatra, 2010; van den Beuken-van 
Everdingen et al., 2016; Vargas-Schaffer, 2010). It was the costliest medical condition to 
treat (Moore et al., 2014; Staton et al., 2007). At any given moment, estimates were that one-
third of the population experienced various pain (Driscoll & Kerns, 2016). What follows are 
descriptions of different conceptualizations of chronic pain and how these models contribute 




Conceptual Models of Pain 
Biomedical Model 
Engel (2012) defined the biomedical model as a factor analytical, reductionist 
approach to treatment. In this model, chronic pain was a symptom of an underlying disease. 
The author further stated that chronic pain treatments focused on the underlying causes of 
chronic pain. This focus tended to ignore any psychological components of the disease. 
Engel believed the primary focus on underlying causes was using the biomedical model of 
pain treatment. The author further stated that when physicians thought the etiology of chronic 
pain was psychological, they often decided that treatment was outside their purview.  
In the biomedical view, masking chronic pain by directly treating it led to increased 
dosages in pain medications and long-term problems, including addiction (Henry et al., 
2015). Pain medications offered only temporary relief and, ideally, should be titrated down to 
zero over time, regardless of whether the underlying, pain-producing conditions were 
resolved (Dowell et al., 2016). Brodal (2017) believed that this reductionist approach to pain, 
however, often caused problems when it confused the experience of pain with its biological 
sources. From a political standpoint, this view was the conservative pain treatment model 
(Wailoo, 2014). 
Peppin et al. (2015) also stated that the strict biomedical model caused systemic 
problems. The authors felt that medical interventions using this paradigm led to 
undertreatment and unnecessary pain. The authors posited that with a strict biomedical, the 
primary focus was on medications and other pharmaceutical industry solutions. Further 




hope of a magic bullet, encouraging interventions that were too often futile and ineffective 
(Deacon, 2013). 
Vardeh et al. (2016), on the other hand, stated that a mechanistic approach to pain 
offered the best long-term hope for pain control. The authors admitted that most pain 
management treatments were inadequate. Nonetheless, Vardeh stated an effective 
intervention might be possible once medicine with an improved understanding of pain 
mechanics. The authors also pointed out that an enhanced understanding of mechanisms 
helped address such pathologies as diabetes and peptic ulcers.  
Biopsychosocial Models 
Engel (1980) contrasted the biomedical model with the biopsychosocial model. In this 
alternative model, the patient was part of a hierarchy of natural systems with levels ranging 
from the biosphere to subatomic particles. According to the author, in the middle of the 
biopsychosocial hierarchy were the patients, including their experiences and behaviors. Engel 
stated, in place of a reductionist approach, a biopsychosocial model included the feelings of a 
patient, the doctor-patient relationship, and any information gleaned from any level of the 
hierarchy that might be useful to the resolution or management of pain (see Figure 1). This 
model has multiplied into various sub-models regarding chronic pain, with many overlapping 












Note. From “The Clinical Application of the Biopsychosocial Model” by G.L. Engel, 1980, 
The American Journal of Psychiatry, 137(5), p. 537. Reprinted with permission, 6/30/2021 





Wade and Halligan (2017) stated that the biopsychosocial model's complexity and the 
lack of a consensus definition of chronic pain had prevented widespread acceptance, despite 
extensive use of the term in research. Yet, the authors felt its influence was growing, and it 
appeared to be the basis of what was called person-centered care. In the illness research 
literature, the various identifiable sub-models that may guide treatment. 
Gate Control Model of Persistent Pain 
Melzack (1990) first postulated the gate control model of pain during cancer 
treatment. The author theorized the existence of a gate in the spinal dorsal horn that acted as 
a switch to turn on and turn off pain before the signal of pain reached the brain. Melzack also 
theorized that there many ways to close this gate, including relaxation and cognitive 
interventions. The gate was opened, however, by fear of pain. Only after the adequate control 
of pain could other interventions work to manage and minimize pain. It put the author in 
agreement with researchers who believed that pain control needed to be achieved first by 
whatever means necessary, including the use of opioids. This model treated addiction and 
adverse side effects as secondary (Bhamb et al., 2006; Chaparro et al., 2014; Compton & 
Volkow, 2006; Finnerup et al., 2015; Gatchel et al., 2014; Henry et al., 2015; Hoffman, 
2016; Katz & Rosenbloom, 2015; Moseley & Butler, 2015). Since then, the gate control 
theory of pain became a widely accepted theory for pain control in cancer treatment (Katz & 
Rosenbloom, 2015; Zhang et al., 2018).). Other biopsychosocial models often incorporated 






Peppin et al. (2015) proposed a new paradigm for pain treatment called the 
complexity model. The authors stated that the complexity model set goals in all appropriate 
areas likely to affect pain management and individualized by circumstances. Peppin 
explained that these areas included: (a) education about pain management, (b) establishing 
pharmacological goals and medication treatment routines, (c) examining and setting goals 
around coping, (d) developing individual and social supports necessary, and (e) developing 
an exercise routine that can exist within the limits of any pain-related disability to increase 
functioning. The authors stated that these criteria were best accomplished when the related 
services were under the same organization, working with the same treatment philosophy. 
Peppin concluded that this model worked collaboratively with the pain patient to address 
their pain's complex nature, with patient satisfaction as the ultimate goal. In more complex 
pain management, the authors added that the use of opioids was necessary for patients in 
persistent, chronic pain. Peppin further stated that a complexity approach must deal with 
patients for whom medications caused more problems than they solved.  
Adjunctive Psychological Model 
Jensen and Turk (2014) offered a review of the various psychological treatments used 
as adjunctive pain management techniques to address non-biological pain and suffering. The 
authors broke these treatments into four categories: strategies to redefine and cognitively 
restructure the perception of pain, education on the etiologies and treatments of pain 
according to the diagnosis, physical exercises and other activities to help cope with pain, and 




research, while helpful, these techniques were not likely to eliminate pain or even adequately 
manage moderate-to-severe pain without medications (Barth et al., 2017; Passik, 2009). 
Nonetheless, research shows they have been useful as an adjunct to coping with persistent 
pain (Ambrose & Golightly, 2015; Berg & Upchurch, 2007; Galvani et al., 2019; McCracken 
& Gutiérrez-Martínez, 2011; McCracken, 1998; Sirois & Wood, 2017; Vlaeyen et al., 2016).  
Neurobiological Model 
This model held out the hope that it may be possible to directly measure pain by 
looking at brain functioning, primarily through brain imaging. It was possible to observe 
which parts of the brain were active when a person was in pain using fMRI and PET scans 
(Flor, 2014). Brodal (2017) stated, while there appeared to be an observable pain network, 
how those areas of the brain interacted, and how it was affected by pain perceptions were not 
well understood. The author noted the brain activated in regions of the pain network when 
the patient reported no pain. Brodal further stated that, with persistent, chronic pain, other 
brain regions, including the cortical gray and white areas, seemed to be affected. The author 
felt this created the possibility for many false alarms in pain determination, and brain 
imaging seemed to confuse pain remembered but not felt. Brodal concluded that using brain 
activation as an objective measure of experienced pain, like blood pressure and heart rate, 
was not yet reliable as an objective measure. Other researchers stated that this model might 
offer hope in understanding why some patients could tolerate chronic pain and others could 




Defining Chronic Pain as a Symptom or Disease 
Engel (1980) was the first to point out that the differences between the biomedical 
model and the biopsychosocial models. These differences focused on whether chronic pain 
was a symptom of an underlying problem (biomedical) or a separate disease 
(biopsychosocial). If it is a symptom, then the underlying problem would be the primary 
focus of treatments (Raffaeli & Arnaudo, 2017). If chronic pain is a separate disease, a more 
holistic approach to pain management would be appropriate (Clauw et al., 2019). 
As previously stated, Robbins (2017) in an editorial suggested that pain-as-disease 
models, particularly when a patient does not complain of pain, have led to the overuse of pain 
medications. The author suggested that the increase in fatal opioid addictions coincided with 
the same period as overzealous pain assessments. Robbins questioned whether there was 
undertreatment in more than 10% of people who complain of postoperative pain. 
Stanos et al. (2016) stated that chronic pain's complexity involved biological, 
psychological, and social interventions. The authors felt that primary care physicians, who 
handle most chronic pain treatment, did not receive adequate training to diagnose and treat 
chronic pain at this level. Morlion et al. (2018) suggested that chronic pain was a separate 
disease and changed treatment focus to quality-of-life criteria. Other researchers criticized 
the biomedical model because it overemphasized medication types and dosages (Melzack, 
1990; Rajagopal, 2011). Pain was also sometimes considered the fifth vital sign, like pulse, 
respiration, body temperature, and blood pressure (Edlund, 2011; Raffaeli & Arnaudo, 2017; 




higher quality of life, by this view, it was considered a fair trade (Kumar et al., 2015; 
Tompkins et al., 2017).  
Treede et al. (2019) described how the International Classifications of Disease (ICD) 
might better classify chronic pain as a separate disease. The authors hoped that those changes 
would develop better treatment pathways, improve patient access to biopsychosocial 
alternatives, and reduce stigma. Treede also stated that opioids might be used long-term 
safely with some people. As will be seen, there was little access to biopsychosocial treatment 
in participants interviewed for this study. How the medical community could improve patient 
access to biopsychosocial treatments under the current classification system will be 
addressed in the results.  
In summary, given the variety of pain models, no testable pain theory, and no 
objective measure of pain, any given pain model's adoption seemed a subjective choice based 
on the treating physician's preferences and training. It indicates that treatments that spring 
from these models have a subjective, interpretive component in assessing and treating pain. 
This subjective component, and its effects, will be further explored in pain treatments. The 
next section also discusses the role of pain models in addiction and undertreatment. 
Pain Treatments 
The ultimate goal in treating pain is to relieve as much pain as possible without 
causing more harm than good (Schuchat et al., 2017; Coghill et al., 2003; Kahan et al., 2006; 
Penders, 2013; Sehgal et al., 2012). While there has been considerable research to develop 




analysis in pain treatment decisions (e.g., Dowell et al., 2016; Gourlay & Heit, 2009; Jensen 
& Turk, 2014). 
Two books devoted to educating pain patients provided a fair comparison of opposite 
approaches to pain treatments. Nagel (2016) focused on the inability of the medical system to 
fully understand and eliminate pain. The author questioned current medical practices and 
assumptions. He also encouraged the use of opioids at the outset, if necessary, to successfully 
manage pain. Over time, Nagel concluded opioids could be reduced and pain better managed, 
but chronic pain control by any means was the best course. Caudill (2016), on the other hand, 
while admitting the limitations of current treatments of pain control, seemed to eschew 
opioids and encouraged pain patients to use non-opioid pain medications and psychosocial 
interventions to control their pain. In the absence of pain relief, the author prescribed 
acceptance and continuously challenging the limitations of pain.  
In general, the research on pain treatment seemed to chart a middle path, as seen by 
the World Health Organization (WHO) recommendations and their guidelines (World Health 
Organization, 2017). Initially, the WHO analgesic ladder was a treatment algorithm urging a 
step-by-step approach to treating cancer pain that sometimes resulted in using opioids 
(Ventafridda et al., 1987). Vargas-Schaffer (2010) stated that this algorithm was modified, by 
WHO and others, several times over the past four decades to include all types of pain. The 
author said that in every iteration, the fundamental recommendations of WHO remained: (a) 
start with oral pain medications, (b) give medications at regular intervals, (c) adjust dosage 
by the intensity of pain, individualize pain treatment, and (d) explain the treatment plan to the 




treatment should vary by diagnosis sometimes caused variations in the WHO analgesic 
ladder (Baker, 2017; Morlion et al., 2018). 
Acute Pain Treatments 
Chronic pain can come directly from the physician's actions when they first 
undertreat acute pain (Gatchel et al., 2014; Kehlet et al., 2006; Nagel, 2016). Gordon et al. 
(2016) reviewed 32 questions recommended when addressing acute surgical pain. The survey 
addressed pain management before, during, and after surgery called perioperative acute pain 
management. The authors admitted that the evidence for those questions was sparse and 
based mostly on the reported experience of physicians who treat pain. Kent et al. (2017) 
postulated that mismanagement of acute pain often results from a poorly defined taxonomy 
that depends on the intensity of the acute pain and its duration. Instead, the authors proposed 
a multidimensional framework of pain management, similar to the complexity model. 
Khidir and Weiner (2016), in a commentary, discussed the dilemma of emergency 
room physicians faced when patients complained of severe pain, where they must give 
treatment under pressure, without longitudinal medical information, and influenced by an 
ever-changing standard of quality care. For instance, Barnett et al. (2017), citing the recent 
rise in opioid dependence as justification, did a study on emergency room physicians who 
prescribed opioids. The study focused on people with Medicare who came to the emergency 
room and had not used an opioid during the previous six months. Barnett then divided the 
emergency room physicians into quartiles, with high-intensity, opioid-prescribing emergency 
room physicians in one quartile. The other physicians ranked in the other three quartiles, with 




high-intensity, opioid-prescribing physicians were more likely to become dependent and 
were more likely to experience injuries within the next 12 months. Barnett acknowledged 
that their Medicare population studied was predominately older adults and that their findings 
were correlations. The authors did not report the effectiveness of pain relief, the quality of 
life of the patients, or why most emergency room doctors in the hospital refused to give any 
opioid medications. Yet, the subjects in the Barnett study probably knew the hospital was 
parsimonious with pain medications. In that case, a person in chronic pain might soon learn 
to go to another hospital or request a particular doctor to treat their complaint. As a result, the 
patients with the most pain, and the most complex medical problems, might be avoiding low-
intensity, opioid-eschewing doctors, leaving them with a healthier population, which could 
account for the effects. 
Cancer Pain Treatments 
As previously mentioned, the assessment and treatment of cancer pain was the first 
use of the WHO analgesic ladder (Bao et al., 2016; Haylock, 2002). Treatment outcomes 
seemed to be most effective with constant assessment and around-the-clock treatment of 
cancer pain with medications (Gatti et al., 2014; Haylock, 2002). As previously mentioned, 
cancer pain was where the medical community first understood the need to recognize and 
aggressively treat needless pain (Melzack, 1990; Katz & Rosenbloom, 2015). Later research 
also supported the idea that adequate control of cancer pain must be a primary treatment 
(Gatchel et al., 2014; Kumar et al., 2015; Radbruch et al., 2013; Seymour et al., 2005). Van 




despite some progress in the past decade, pain in cancer patients remained a problem and 
needed more research. 
Noncancerous Chronic Pain Treatments 
The same algorithm as chronic, non-cancer pain guided the treatment of persistent 
pain and chronic regional pain. Despite its ubiquity, chronic, noncancerous pain remained the 
most complex and complicated treatment (e.g., Honey et al., 2016; Volkow & McLellan, 
2016). Dowell et al. (2016), using a strict, evidence-based biomedical model, believed that 
opioid medications should be titrated down and eliminated over time, regardless of the 
resolution of the underlying, pain-producing conditions. The authors stated that titration 
down, either through persuasion or coercion, provides for the patient's overall health. Dowell 
allowed exceptions in cancer treatment, palliative care, and end-of-life care. The authors 
claimed that it risked an increase in iatrogenic addiction if the primary goal of treating 
noncancerous, chronic pain was pain relief. Dowell defined iatrogenic addiction as an 
increase in addiction caused by physicians over-prescribing pain medications. The authors 
postulated that doctors could avoid this increase by prescribing fewer opioid medications as a 
general practice.  
Dowell et al. (2016) further recommended that doctors assess the risks and benefits of 
opioid use, though they offered no specific recommendations for determining benefits. By 
focusing solely on the risks, the authors seemed to support the strict, biomedical point-of-
view. However, by giving a palliative care exception, Dowell left room for long-term opioid 
medication use. Still, the authors did not define when that decision was an acceptable risk. 




despite whether pain remained severe, quality-of-life compromised, or undertreatment was 
evident (Bhamb et al., 2006; Chaparro et al., 2014; Compton & Volkow, 2006; Finnerup et 
al., 2015; Henry et al., 2015; Hoffman, 2016; Moseley & Butler, 2015). 
Biopsychosocial pain treatment models viewed opioids and other potentially 
addictive medications very differently (e.g., Gourlay & Heit, 2009). In some of these pain 
models, drugs were administered immediately at an adequate dose, for as long as necessary, 
to manage pain (Kumar et al., 2015; Rajagopal, 2011). Other models followed the WHO 
algorithm, slowly increased the type of pain medication, and then gradually reduced the 
drugs to their lowest effective dose (Finnerup et al., 2015; Gatchel et al., 2014). They 
addressed any secondary problems (e.g., addiction, misuse, tolerance, etc.) through harm 
reduction programs (Gourlay et al., 2005). These treatment models collectively advocated 
using quality-of-life criteria rather than an enforced reduction of medications (Kumar et al., 
2015; Rajagopal, 2011).  
The next section will address addiction and fears of addiction.  It will also discuss 
when patients in pain reported inadequate treatments or researchers found what they 
concluded was undertreatment. Finally, the section discusses how this lack of treatment may 
sometimes result from stigma. 
Undertreatment of Pain 
With no objective measure of pain, factors outside of the doctor/patient relationship 
influenced the prevalence of adequately or inadequately treated pain (Wailoo, 2014). Peppin 
et al. (2015), in a commentary, addressed how the expanding population of pain patients 




posited that the complexity of treating chronic pain led to undertreatment due to: (a) lack of 
reimbursement for a thorough assessment; (b) lack of physician training, particularly in the 
psychological effects of pain; and (c) treatment models that focused on procedures and 
symptoms rather than outcomes. Peppin also concluded that these factors led to the 
undertreatment of pain. 
Gatchel et al. (2014) wrote a commentary on why pain clinics were not addressing the 
problem of undertreated chronic pain, which they believed was widespread. The authors 
differentiated between a multidisciplinary approach and an interdisciplinary approach. 
Gatchel stated that a multidisciplinary approach included different professionals who 
intervened in other locations, with limited communication and few shared intervention 
philosophies. The authors contrasted this with an interdisciplinary approach, when all 
professionals were in the same place, in constant contact, and used the same treatment 
philosophy. Gatchel admitted that an interdisciplinary approach's upfront costs were higher, 
and insurance companies tended not to approve these more complex interventions. The 
authors concluded that this ignored the fact that long-term expenses were much lower in an 
interdisciplinary approach, and outcomes were better.  
Finnerup et al. (2015), in a literature review of 229 studies on the evidence-based 
treatment for chronic pain, found a widespread lack of treatment. The authors reviewed 
studies on undertreatment, under-diagnosis, pain treatment effectiveness (50% reduction in 
pain), and pain treatment costs. Finnerup focused primarily on randomized controlled studies 
from peer-reviewed journals with estimated effect sizes when that data was missing from the 




no differences in effectiveness in the medications used for pain control. The authors also 
found 10% of the research overstated the effects of their pain treatment. Finally, Finnerup 
found the research standard for properly managed pain (50% reduction) varied according to 
individual response. The authors concluded there was evidence of unmet need in pain 
management outcomes.  
Breivik et al. (2006), in an international survey of 15 European countries and Israel, 
also reported prevalent unmet need in chronic pain treatments. The researchers used 
telephone interviews with over 45,000 individuals experiencing chronic pain, some for over 
six months. Breivik studied various medication treatments, including NSAIDs, weak opioids, 
paracetamol, COX-2 inhibitors, and strong opioids. The authors found about 40% of the 
individuals surveyed still reported inadequate pain management. Breivik also found that 
moderate-to-severe chronic pain continued to occur in about 40% of adults. The authors 
concluded that undertreatment was evident in the chronic pain population. 
Bhamb et al. (2006) published a survey of 248 primary care physicians on their 
treatment of chronic pain: (a) what medications they used, (b) what diagnoses necessitated 
opioid medications, and (c) how they guarded against abuse or other forms of addiction when 
prescribing opioids. The authors found that doctors said they felt comfortable prescribing 
opioids during cancer treatment and terminal illness. Breivik found that doctors did not feel 
comfortable prescribing opioids for non-cancerous pain. The authors found that the primary 
concerns of the doctors in those situations were ranked: (a) patients were abusing 




(e) lack of training on how to choose opioid medications. The authors concluded that there 
was evidence of untreated pain after treatment. 
Bruehl et al. (2015), in an experiment on the treatment of lower back pain, tested a 
screening questionnaire proposed for use by physicians who hoped to supplement their 
clinical judgment with objective analysis on the likelihood of later addiction during opioids 
use for chronic pain treatment. The goal of the authors was to impact the rising rate of opioid 
abuse. Bruehl hypothesized that their screening questionnaire might predict future opioid 
abuse because it tapped into individual differences in opioid responses. The authors did find 
that one group reportedly liked morphine more than other groups with lower scores on their 
questionnaire. Bruehl postulated that these subjects were more likely to become addicted. 
However, one limitation of this prediction was that the authors were unable to separate the 
influence of pseudoaddiction. It was a label Bruehl gave to subjects who had undertreated 
pain before participating in the study. As a result, the authors could not separate addiction 
from pain relief in the group that said they liked the medication. 
Rajagopal (2011) wrote a commentary on his experience with long-term, refractory 
pain. As a patient, he endured severe pain until his condition eventually improved, a painful, 
year-long struggle. As a specialist in palliative care, Rajagopal was shocked when his fellow 
clinicians ignored treatable pain and seemed not to understand that pain relief was necessary. 
The author identified six sources of these misunderstandings: (a) a lack of resources, 
particularly in the developing world; (b) a lack of education in palliative care strategies; (c) 
government and industry regulations that were too focused on treatment rather than pain 




community of the experience of chronic pain. Rajagopal felt that this lack of recognition 
came from the paucity of research on the experience of long-term, refractory pain in non-
cancerous, chronic pain conditions. The author concluded that narrative research on the 
experiences of chronic pain patients might fill this gap. 
Rivera et al. (2015) was a qualitative survey of 3,029 pain patients that focused on the 
quality of their lives after three months of treatment. The study was limited to patients with 
moderate to severe pain, with chronic pain duration of up to seven years. The survey 
measured: (a) ability to self-care independently, (b) participation in usual activities, (c) levels 
of pain and discomfort, and (d) levels of anxiety or depression. The authors concluded that 
there was evidence of quality-of-life improvements in approximately half of the subjects 
interviewed. The lack of progress in the other half showed evidence of undertreated pain. 
Rivera concluded that the severity of pain and interference with usual activities significantly 
impacted quality-of-life. 
While many doctors expect cancer pain to resolve as the treatment progressed, 
research showed that from 33% to 45% did not receive adequate cancer pain treatment 
(Vuong et al., 2016). Other research showed that undertreatment existed at cancer treatment 
centers even with multiple treatment modalities (Haumann et al., 2017; van den Beuken-van 
Everdingen et al., 2016). Gatti et al. (2014) found that breakthrough pain was highest in 
cancer patients who had undertreated baseline pain.  
Undertreated, persistent pain also exists in acute pain populations. Undertreated pain 
was reported: (a) in emergency rooms (Paydar et al., 2016; Platts-Mills et al., 2016); (b) after 




(Trentin et al., 2001); (d) after major surgery (Singh et al., 2016; Sinatra, 2010); and (e) in 
outpatient treatment centers (Emilson et al., 2017; Hayes & Hodson, 2011; Kehlet et al., 
2006). Undertreated, persistent pain had also been found: (a) in addicts both with and without 
treatment for addiction (Nordmann et al., 2017); (b) in older adults, particularly in nursing 
homes (Arnstein, & Herr, 2017; Björk et al., 2016); (c) in people with mental illnesses 
(Abdallah & Geha, 2017); and (e) in children (Hiller & Suominen, 2017). These data 
supported Siddall & Cousins (2004) contention that persistent pain caused a separate disease 
state that could be more serious than the original pathology that caused chronic pain, 
negatively affecting treatment decisions. 
In summary, prior research has shown that the undertreatment of pain was evident in 
all pain populations. It seemed particularly likely in moderate-to-severe pain, even when the 
duration of the experienced pain was short. The literature indicated that the propensity to 
undertreat pain might be due to: (a) fear of medication misuse, abuse, or addiction; (b) fear of 
adverse side-effects; (c) lack of clear diagnostic criteria; (d) lack of training; (e) pressure 
from government and professional organizations; (f) social stigmatization of pain patients; 
and (g) systemic bias in the medical research and practice (Bell & Salmon, 2009; Bhamb et 
al., 2006; Chapman et al., 2010; Gourlay et al., 2005; Peppin et al., 2015; Rajagopal, 2011). 
As Wailoo (2104) stated, some of these factors were outside of the typical doctor-patient 
relationship and were part of the broader social system. 
Systemic Factors That Influence the Assessment and Treatment of Pain 
A review of the literature revealed a lack of understanding on whether the 




of good medical practice, or (c) was an interaction of the two that may depend on 
circumstances or individual responses (e.g., Chapman, & Gavrin, 1999; Chapman et al., 
2010). Peppin et al. (2015) stated that these factors overwhelm busy primary care doctors, 
mainly because of many factors out of their control. The authors said it was relevant to 
examine the “macro-level” or systemic forces that influence how pain and pain patients are 
perceived, assessed, and treated.  
Fears of Addiction 
The epidemiological trend documenting the rise in opiate addiction has further 
increased the possibility of persistent pain undertreatment (Rajagopal, 2011). As previously 
stated, the CDC reported that there were 1.9 million people who abused or became dependent 
on opioids in 2013. From 1999 to 2014, opioid addiction increased and caused 160,000 
deaths. Yet, opioid prescription use dropped 13% between 2012-2015, with no decrease in 
opioid deaths. This result brings into question the causal role of opioid prescribers (Schuchat 
et al., 2017).  
Nonetheless, other studies continued to assert that the over-prescription of opioid 
medications caused the opioid epidemic (Ballentine, 2010; Dowell et al., 2016). In an 
epidemiological study, Compton and Volkow (2006) theorized that the increased use of 
opioids to treat pain caused an increased availability of opioids, fueling an epidemic. While 
focusing primarily on prescribing physicians, the authors suggested increased vigilance in the 
use of opioid medications. Compton and Volkow (2006) also suggested increased research 




Henry et al. (2015) studied the increase in opioid dosages for 246 patients treated 
with opioid medications, termed drug escalation. The authors studied the increased likelihood 
of addiction resulting from high-dose opioid use versus lower doses. Henry surveyed the 
hospital records of people given opioids for pain who were naive to opioid medications. The 
authors defined this as no documented opioid use for the past year. Henry also limited their 
subjects to those with skeletomuscular pain but no other comorbid, pain-producing 
conditions. The authors measured dosages in prescription-dose-days to account for 
participants who took intermittent doses. Henry also measured office visits, emergency room 
visits, nursing visits, telephone consultations, refill requests, and patient emails. The authors 
used mixed-effects regression analysis to differentiate the groups who did not have dose 
escalation from those who did. Once separated, Henry used a Wilcoxon two-sample test for 
continuous variables and Fisher’s exact test for categorical and dichotomous variables. The 
authors found that subjects identified as having dose escalation were more likely to be 
substance abusers, had more frequent office visits, and was evident in the first year of opioid 
use. Henry felt that early escalation of opioid doses in the first year might predict later 
addiction, but further study was necessary. The authors mentioned, however, that 
pseudoaddiction (i.e., undertreatment) could also explain those results.  
Alternate Explanations for the Rise in Addictions 
However, other researchers suggested that prescribers may not be the primary cause 
of increased addiction. According to Sullivan and Levin (2016), more pain-producing 
conditions might have resulted from an increased number of older baby boomers with 




medications for pain control. Also, there was little evidence that reducing addictive pain 
medication prescriptions would lead to better long-term pain management (Finnerup et al., 
2015). Long-term pain management might require a personalized pain genotype, the 
identification of which needed more progress in neurological research (Bruehl et al., 2015). 
Exaggerated Fears of Addiction 
Vowles et al. (2015), in a meta-analysis, documented the overlapping definitions in 
pain research and the tendency to overestimate the prevalence and severity of increased 
social problems with opioid use. According to the analysis, the author concluded that only 
three terms used in the research were distinct and measured different pain medication 
problems: (a) misuse, where the patient used medications in a way not prescribed by a doctor 
(e.g., taking pain medication given to a spouse); (b) abuse, where the patient used a drug in a 
medically unintended way (e.g., taking prescription medications for recreational purposes); 
and (c) addiction where pain medications were repeatedly taken, or craved, despite apparent 
harm and no medical benefit. Vowles et al. (2015) postulated that using non-overlapping 
definitions would eventually bring consensus to the prevalence, treatment, and pain 
management outcomes.  
In a classic study, Heit (2001) stated that only two in ten patients (20%) on long-term 
opioid medications became addicted when treated with opioids. Another 20% had side-
effects associated with the long-term use of opioids. The author called these secondary 
conditions adverse drug events. The author stated that addiction prevalence data conflated 
these secondary conditions with addiction. Opioids could be safe long-term for the remaining 




relegate these patients to needless suffering and unnecessarily lower their quality of life. 
(Chapman et al., 2010; Gourlay et al., 2005; Kumar et al., 2015; Rajagopal, 2011; Vowles et 
al., 2015). 
Robins et al. (1974) in a classic study on addiction among veterans returning from the 
Vietnam War found that heroin use, which was considered an epidemic among Vietnam 
veterans in 1973, dropped from 60% to 10% one year after returning home. The authors 
found that among those who continued to use heroin, they had a high probability of addictive 
behaviors before being deployed. In a follow-up lecture, Robins (1993) stated that the data 
from his previous study had withstood the test of time. No other factor explained the result 
except that using heroin does not lead always lead to addiction. Treatment outcomes 
involving the use of long-opioids for pain control backed up this conclusion (Kumar et al., 
2015; Passik, 2009; Rajagopal, 2011). 
In summary, while the rise in addiction is undeniable, its true causes are in question. 
Sanctioning doctors and prescription monitoring programs may result from an over-
simplified understanding of the complex nature of pain and its treatment. Changing 
population characteristics (aging), cultural changes in the acceptability of medication for 
pain, and the promotion of opioids by pharmaceutical companies for use for conditions and 
symptoms not appropriate for opioid use may all contribute to the current U.S. opioid 
controversy. The rise of heroin and opioid addiction, particularly in older and Caucasian 
demographics, may not be caused primarily by the over-prescription of pain medications. For 




understanding of chronic pain and its confusion with other types of suffering, we must 
consider other factors.  
Effects of Bias on Pain Treatment Decisions 
Chapman et al. (2013) defined explicit bias as a consciously expressed stereotype that 
may be partially true for a group but does not predict the characteristics of any particular 
member of that group (e.g., men like watching sports). The authors stated that bias could be 
positive (e.g., rich men make good husbands) or negative (e.g., rich men make untrustworthy 
sexual partners). Chapman defined implicit bias, on the other hand, as an unconscious belief 
often denied by people who hold that belief. It was only evident through actions or decisions 
(e.g., I believe women can be as good as men, but I have never met one I would hire). In 
healthcare research, training controlled much of explicit bias. Yet, implicit bias has been 
documented and may be prevalent (Zestcott et al., 2016). 
Systemic Pain Bias 
Berry and Dahl (2000) stated that one professional organization that addressed 
persistent pain was the Joint Commission, formerly known as JCAHO. The authors stated 
that, at the turn of this century, the goal of the Joint Commission was to address the prevalent 
undertreatment of both acute and chronic pain in all clinical settings and includes: (a) 
emergency rooms, (b) post-operative care, (c) burn centers, (d) cancer treatment, (e) 
outpatient centers, (f) primary care offices, and even (g) at-home care. Berry and Dahl 
concluded that these standards would address unrelieved pain costs and that appropriate pain 
management was a right, not a privilege. Baker (2017) stated that, over the next 16 years, the 




that period, the author contended, the focus of the pain research shifted from undertreatment 
and became: (a) moving away from narcotic pain medications, (b) improving quality of life 
factors in pain management, (c) developing non-narcotic pain medications and nerve blocks, 
and (d) developing psychosocial pain treatments.  
Baker (2017) stated JCAHO remained concerned about the prevalence of 
undertreatment. The author concluded that the accrediting commission kept four 
recommendations: (a) engage all stakeholders, including the patients, in determining 
standards; (b) anticipate, monitor for, and address unintended consequences; (c) ensure that 
the survey algorithms of the JCAHO continually test against a focus on easily measurable 
observations that negatively influence quality outcomes (e.g., the sole use of rating scales); 
and (d) keep survey standards abreast of the most recent research. Baker showed that JCAHO 
had yet to achieve its goal to treat pain relief as a right. So unnecessary pain may still occur if 
physicians limit themselves solely to the biomedical model to treat pain.  
Government Influence on Pain Bias 
On the other hand, the federal government significantly influenced the perception of a 
causal link between addiction and prescription pain medication abuse (Cole, 2011). Hari 
(2016) stated the first federal agency charged with enforcing the laws against narcotic drugs 
was the Federal Bureau of Narcotics. The author added that it replaced the agency designated 
to enforce the prohibition of alcohol in the 1930s. Hari also said that, from its very inception, 
this replacement agency deliberately promoted racist arguments. The current federal drug 
enforcement agency, called the Drug Enforcement Agency (DEA), continued racial biases in 




on blacks and Hispanics (Bobo & Thompson, 2006). It helped create the school-to-prison 
pipeline, incarcerating minorities, and low-income individuals, while being more lenient with 
others who committed the same offenses (Ruiz, 2016).  
In addition to the CDC issued guidelines against the long-term use of opioids, Tran et 
al. (2017) posited that the Federal Drug Administration (FDA) had a role in creating rules 
designed to prevent opioid abuse. The authors pointed out that the biggest, recent change in 
regulations was the rescheduling of hydrocodone from Schedule III, a drug with limited 
abuse potential, to Schedule II, one of high abuse potential but still medically useful. The 
authors described other FDA inspired changes that so far have had only modest effects 
included: (a) warning labels on medications with abuse potential; and (b) promoting 
computerized risk management databases that monitored who was prescribing and who used 
potentially addictive prescription drugs.  
Windle (2016) said efforts to curb opioid use showed the government appeared to be 
firmly on the side of controlling the opioid epidemic by restricting medical prescriptions. The 
author openly questioned whether the federal government had tipped the scale on the 
perception of persistent pain patients. Windle documented that various government agencies, 
whose goal was to stigmatize, and sometimes criminalize, the use of painkillers, and how it 
worked against agencies concerned with quality-of-life and pain relief (e.g., JCAHO). The 
author further stated that this was difficult for nurses at the frontlines of pain control and 
trained to be patient-centered. Windle concluded that advocating for pain relief often puts 




Other Organizational Sources of Systematic Bias 
Sismondo (2008), in a meta-analysis, contended that the pharmaceutical industry 
created publication bias, often intentionally, because it resulted in higher profits. The author 
stated that pharmaceutical companies accomplished this through ghost management, where 
unacknowledged advisors designed studies, edited the reports, and then promoted the results. 
Sismondo also stated that ghost management: (a) tended to attract more future funding; (b) 
marginalized non-aligned academic researchers; (c) skewed the number of publications in the 
direction of new, expensive drugs favored by the industry; (d) made it more likely to earn 
FDA approval; and (e) tended to hide side effects, contravening research, or possible 
alternate treatments. It supported and gave some context to the later assertion that pain 
research was too focused on medication treatments (Peppin et al., 2015). 
Eaves (2015) did a qualitative study on how people with chronic pain used OTC 
analgesics to mitigate their chronic pain rather than more effective prescription medications 
when in moderate-to-severe pain. The author found that advertising from drug companies 
was a major contributing factor in the inappropriate use of OTC analgesics. Eaves (2015) 
stated that advertising was also responsible for perceiving these drugs as harmless, further 
stigmatizing opioids as a possible good alternative. As such, the author contended, their use 
was often not discussed when seeking medical advice for pain, even when dosages were 
critical to an accurate diagnosis and the possibility of drug interactions. Eaves stated that the 
reasons for not using prescription medications include: (a) saving more effective medications 
for more severe pain; (b) feeling that prescription medications masked the chronic pain and 




medications would impair ability (e.g., thinking, driving, operating heavy machinery, etc.) 
and (e) concerns about addiction. The author concluded that these were why people used 
OTC medications in larger dosages than recommended, sometimes to the point where they 
could harm. 
Cooper (2013a) did a literature review on the abuse of OTC medications in general. 
The author found that the problem was international in scope and little understood. A 
qualitative study by the same author, done on people who believed they could become 
addicted to OTC drugs, found: (a) while admitting their addiction, OTC drug abusers 
differentiated themselves from addicts who used prescription drugs or illegal drugs; (b) those 
who self-identified as addicts had formerly used prescription drugs for the same condition; 
(c) codeine was the drug most often mentioned in OTC addiction, but Cooper indicated other 
possibly addicting OTC drugs (e.g., pseudoephedrine, diphenhydramine; other cold remedies, 
etc.); and (d) those self-identified with OTC drug addiction tended to avoid treatment 
because they felt their addiction was more acceptable (Cooper, 2013b). Cooper (2018) later 
asserted that OTC addiction was real, tended to be ignored, and was not completely 
understood. Chhatre et al. (2017) said OTC drugs might be responsible for the general 
increase in older adult addiction. Stone et al. (2017) also stated that misuse was in the older 
populations, with drug interactions was the most common form of misuse. Other research 
found that differing adverse effects of various analgesics might confuse the user. This 
misunderstanding appeared to involve the method the FDA used to label the impact of 
several types of OTC pain medications and their side-effects, particularly for older adults 




Meier (2018) documented evidence that drug companies lied about the addictive 
nature of their opioid medications. The author contended that drug companies knew their 
medications were addictive as soon as 1996. Nonetheless, these companies promoted their 
pills as less addictive to doctors until 2007. Meier found that early on, federal government 
employees discovered this deception but were told by upper Bush administration officials in 
the Department of Justice (DOJ) not to pursue an investigation. Instead, the author stated that 
Perdue Pharma, convicted on one charge of misbranding, blamed the promotion on a few 
rogue employees. The resulting fine was a fraction of the profit Perdue made over the years 
of its legal challenges. 
Sources of Pain Bias from Healthcare Providers 
Staton et al. (2007) found that the increased costs for treating chronic pain may be 
due to its ubiquity. The author further stated that this ubiquity could be based in 
undertreatment. Using the 0-10 rating scale for pain, Staton independently asked patients to 
rate their pain. The authors then asked the treating physician to rate the chronic pain of the 
same patient. When there was a 2 point or greater difference, Staton labeled it as a 
disagreement. The authors found that doctors consistently underestimated the intensity of 
pain in their patients with chronic pain. The authors concluded that the factors that drove this 
underestimation included: (a) lack of doctor training, (b) not appreciating the emotional 
aspects that may exacerbate chronic pain, (c) fear of side effects or addiction, and (d) the 
clinical judgment that complaints of pain were malingering. Staton found regular 




The authors added that chronic pain perception differences often appeared when the patients 
were from an ethnic minority.  
Bell and Salmon (2009) looked at pseudoaddiction (another label for undertreatment) 
and bias. In a meta-analysis, the authors also found a reluctance of doctors to prescribe 
opioids. Bell and Salmon stated that three factors were behind this reluctance: (a) lack of 
physician training; (b) prejudices against the use of opioids to treat pain (opiophobia); and (c) 
government legal restrictions on the use of opioids even when clinically necessary to control 
pain. The authors also found that pseudoaddiction was applied when treating white people 
with opioids but less often used when treating minorities, particularly black patients, with 
similar afflictions. 
Althubaiti (2016) addressed the problem of confirmation bias in medicine. The author 
stated that confirmation bias was when decisions were made according to the medical 
provider’s presumptions, opinions, or predilections. Althubaiti went on to state that 
confirmation bias was possible in any medical decision that required judgement. The author 
stated that confirmation bias was best controlled by always acknowledging the possibility of 
bias, being objective with evidence, accepting to advances in thinking, and taking into 
account contradictory evidence. 
Publication Bias in Pain Research 
Calati et al. (2015) did a literature review of research on the relationship between 
suicide and severe pain. The authors searched 159 studies in MEDLINE and PsychINFO 
until 2015, with 31 articles meeting their search criteria. Calati reviewed studies on both 




including ideations, suicidal plans, attempts, and completions. Calati commented that 
underestimating chronic pain may affect suicide rates. 
Calati et al. (2015) did not attempt to change their conclusions based on the 
possibility of confirmation bias. The authors' primary judgment was that, as the severity of 
the pain increased, the likelihood of suicidal behavior also increased. Calati suggested more 
studies on why some people resisted severe chronic pain and others did not. A later review 
indicated confirmation bias in suicide pain research, and the relationship between suicide and 
chronic pain was more substantial than reported (Stubbs, 2016). 
Some researchers discounted research that did not use quantitative, randomly 
controlled studies (e.g., Vowles et al., 2020; Dowell et al., 2016). Others discounted pains 
studies that had small effect sizes (Finnerup et al., 2015). This judgment tended to exclude all 
research based on narrative and other qualitative methods. Yet, quantitative studies on pain 
based their numbers on statements extracted from surveys and pain scales. (e.g., Wong et al., 
2015), which could be quantifying qualitative self-reports. 
In summary, bias was a conscious or unconscious prejudgment based on stereotypes 
instead of experience, observations, and facts. It had multiple sources, and it was complicated 
to address. However, unaddressed, it could stigmatize people in persistent pain. Bias in pain 
management research resulted from: (a) mutable definitions of pain, rating scales, and 
surveys that do not fully reflect the experience of pain; (b) treatments that vary by the pain 
model used; and (c) bias, whether implicit or explicit. Limiting information to evidence-




to our understanding of pain. One area that could increase our awareness of chronic pain 
would be to examine the feelings of stigma and the effects of bias on pain patients. 
Role of Stigma 
The study of stigma has a long history in social psychology, particularly on the 
effects of social isolation (Cacioppo et al., 2015; Hawkley & Capitanio, 2015; Oliveira et al., 
2015). Major et al. (1998) defined stigma as a social identity spoiled by repeated negative 
bias experiences. The authors contended that a negative social identity affected the reputation 
and treatment of a person or group.  
Jackson (2005) wrote a comprehensive essay on why chronic pain sufferers, despite 
their ubiquity, posed a threat to a cultural definition of social order. In ordinary, face-to-face 
encounters, the author stated that chronic pain sufferers learned to hide their affliction 
because they might be disturbing and threatening to other people. Jackson postulated that 
stigmatization was expected, even among chronic pain sufferers who negatively judged 
others in chronic pain. The author further suggested this stigmatization resulted from the pain 
sufferers' changing social roles that might put them in social limbo between their former and 
current social classifications. Jackson concluded this uncertainty was threatening because the 
sufferer's social role was no longer easily understood. The author labeled this social 
displacement due to these uncertainties as liminality. 
Monsivais (2013) studied 15 Mexican American women who experienced persistent, 
chronic pain. The study focused on stigma in three forms: (a) social, (b) self, and (c) 
systemic. The author also added perspectives on how their culture and gender roles 




made it more challenging to fulfill traditional roles expected of Mexican American women. 
The author concluded that this lack of understanding in their support system created family, 
work, and medical treatment problems. Monsivais added that Mexican American women 
(and women in general) learned to hide their pain, avoid complaining, and overexert (at least 
in terms of their disability). The author also contended that women avoided people who were 
likely to judge them, including medical providers. Monsivais stated that the resulting 
stigmatization potentially prolonged their healing process and prevented good outcomes. The 
author concluded that to prevent stigma, treatments needed to involve the patient by 
understanding how stigmatization causes harm. Monsivais also postulated that such an 
understanding might give medical personnel the ability to ameliorate those causes instead of 
unintentionally making them worse. 
As stated above, in a telephone survey of over 46,000 subjects, including 15 
European countries and Israel, 40% of the subjects reported undertreatment and stigma 
(Breivik et al., 2006). In qualitative research that explored the role of exercise in treating 
chronic lower back pain, subjects reported stigmatization in every focus group (Slade et al., 
2009). De C Williams (2016) did a topical review of stigma when treating pain in clinical 
settings. The author stated that research showed subjects reported stigma due to 
undertreatment and lack of proper assessment. De C Williams further noted that many other 
studies on treating chronic pain showed stigma reports. The author also noted that little 
research looked at the causes of stigma or how to alleviate stigma. The author also felt that 
stigma was less likely if the patient complied with medical advice. De C Williams found that 




and stigma. The author also found bias in that pain should be short-term, based on an 
observable physical disorder, and fixable. On the other hand, De C Williams concluded that 
persistent pain was suspect and often stigmatized. 
Werner et al. (2004) conducted a qualitative study on ten women with persistent, 
chronic pain who recounted their feelings of self-shame and the experience of stigmatization. 
The study documented their attempts to: (a) negotiate care; (b) deal with the prejudice of 
family, friends, and acquaintances; and (c) deal with their self-shaming. The authors 
concluded that these were characteristic results of stigma. Werner further found that the 
woman tended to distance themselves from others experiencing pain and often said that 
talking about chronic pain was boring. The authors theorized that this allowed them to avoid 
any discussion regarding the psychological causes of pain and its social stigmatization. 
Wilbers (2015) conducted a qualitative autoethnography of her experience supporting 
her mother, who lived with persistent, chronic pain for 14 years due to a degenerative spinal 
condition. The author stated that, as the disease progressed, opioid medications became the 
only effective treatment. Wilbers described: (a) multiple episodes of stigmatization of her 
mother; (b) difficulty getting effective treatment; (c) unfounded accusations that her mother 
was an addict; (d) multiple instances of negative feedback from the author’s students, friends, 
family, doctors, and even randomly encountered strangers when she discussed the situation 
with others; and (e) multiple occasions where there was fear that the doctor might take away 
her mother’s medications and leave her mother in despair. The author concluded that her 
mother was stigmatized and presented with unneeded stress. The weakness of this study: 




Waugh et al. (2014) studied 92 adults with persistent, chronic pain who answered a 
questionnaire on their negative experiences with stigma. The authors differentiated between 
social stigma, structural stigma, and internalized stigma. Waugh found that internalized 
stigma, defined as expecting to experience stigma even in the absence of any environmental 
triggers, was the predominant feeling expressed. The authors concluded that internalized 
stigma was a factor in treating chronic pain and needed to be addressed concurrently with all 
medical interventions. 
Wong et al. (2015) conducted multiple surveys on 178 Chinese chronic pain patients' 
quality of life, some suffering from persistent pain for up to 10 years. According to the 
authors, Asian clinics differed culturally from western clinics. Asian patients tended to use 
more passive coping methods, which means they were more likely to accept medical advice 
without question. The subjects in Wong were also less likely to have the same doctor over 
time, as their doctors often changed from visit to visit. The authors concluded that the 
severity of pain and anxiety/depression were most likely to predict lower patient satisfaction 
and quality of life. Depression and lower patient satisfaction, either caused or exacerbated by 
stigma, had deleterious effects on medical treatment outcomes (e.g., Phelan et al., 2015) 
In a review of the narrative literature on pain, Newton et al. (2013) studied the effects 
of disbelief on stigma. The authors used the term delegitimation, defined as when medical 
professionals did not believe reports of pain. Newton found five sources of this phenomenon: 
(a) felt stigma even in the absence of anything said by the doctor; (b) biological explanations 
used to disconfirm reports of pain; (c) challenges to the personal integrity of a patient; (d) 




interpreting pain reports as psychologically-based complaints. Other research showed 
disbelief was evident beyond the doctor/patient relationship. It appeared in different kinds of 
relationships, including friends and family (Armentor, 2017). Research showed that even 
when medical providers closely questioned their patients about their pain, stigma was still a 
potential problem. In those instances, the goal appeared to persuade patients to follow given 
medical advice even when it did not conform to patient beliefs (de C Williams, 2016; 
Moseley & Butler, 2015; Zanini et al., 2016).  
In summary, stigma was evident in various pain studies, some even when it was not 
the focus of the research. The emotional impact of a chronic pain condition lowered the 
ability to manage pain. The internalized effects of social stigma added to the adverse 
consequences of chronic pain, even when there were no bias reports. Logically, if physicians 
used a strictly biomedical model to treat pain, and they too often ignored emotional factors, it 
may create an increased possibility of stigma and the undertreatment of unnecessary pain. 
Theoretical Frameworks 
The development of the methods and analyses in this study followed two theoretical 
frameworks, social identity theory and attribution theory. These two theories explained the 
changes in the self-concept of chronic pain suffered and possible sources of stigma. 
Social Identity Theory 
Social identity theory evolved in the early 1960s from Henri Tajfel, an experimental 
social psychologist dedicated to making social psychology less reductionist (Dumont & 
Louw, 2007). It postulated that social identities evolved from the need to develop and 




The accentuation principle often defined social roles. Here individuals may take many forms 
of social identity within a group, according to their immediate perceptions (Trepte, 2006). 
Augoustinos et al. (2014) stated that no one theory defined all types of attributions. The 
author went on to say current research on social identity theory was better able to explain 
accentuation, bias, types of prejudice, and the formation of social identity. 
Monsivais (2013) applied social identity theory to understanding how individuals 
who live with chronic pain see themselves compared to others. The author stated that 
individuals with chronic pain identify within a group according to how openly they express 
their illness to others. The author also said moderate-to-severe chronic pain was difficult to 
hide. Monsivais concluded that this could result from a change in social roles imposed due to 
the pain condition.  
Sturgeon and Zautra (2016), in a review of research on resilience to pain, stated that 
both physical pain and social pain shared pathways of the brain pain network. The authors 
labeled social pain as anxiety that came from social isolation and stigma. Sturgeon and 
Zautra speculated that addressing social isolation and other adverse social effects common to 
pain patients would increase resilience.  
Sheedy et al. (2017), in a mixed design on the factors that promote resilience to pain, 
found several negative experiences related to an inability to cope with chronic pain. The 
authors stated these experiences included: (a) losses due to chronic pain (e.g., the failure to 
resume previous activities; work/money losses; loss of ability to self-care, etc.); (b) 
experiencing adverse social events due to pain (e.g., loss of friends; disbelief when they 




esteem; lowered self-confidence; spoiled reputation, etc.); and (d) more negative mood 
including increased anger and intolerance to minor stresses. The lowering of resilience to 
pain and the effects of stigma and disbelief on chronic pain seemed to have similar 
antecedents (e.g., de C Williams, 2016; Waugh et al., 2014). 
Attribution Theory 
Augoustinos et al. (2014) stated that attribution theory, a form of social identity 
theory, dealt with how people created causal explanations in the absence of objective 
evidence. Despite years of research, the author concluded that the literature revealed 
competing theories about why people make causal explanations when the facts are not known 
or even knowable. Augoustinos identified the problem as being within the research itself. 
The authors stated that attribution researchers had trouble distinguishing the actual responses 
from response bias, where the subjects hid their true feelings and gave a more socially 
acceptable answer. 
Since it is not possible to measure chronic pain except by self-report, attribution 
theory was useful in understanding why patients and doctors disagreed on the severity and 
causes of persistent pain (Katz & Rosenbloom, 2015; Newton et al., 2013). Being under 
pressure by their professional organization and governmental agencies to reduce opioid 
prescriptions, attribution bias could also explain why doctors sometimes chose treatments 
that were self-serving (Coleman, 2011; Macciocchi & Eaton, 1995). These factors could be 
added to stigma and bias concern advocates of the humanization of pain treatment have 




Narrative research is also affected by another aspect of attribution theory, hindsight 
bias (Groß et al., 2017). Roese and Olson (1996) defined hindsight bias as an after-the-fact 
judgment of a past event, introducing new knowledge not available at the time of the 
decision. More than just the recall of an event, it is a substitution of a new causal explanation 
imposed without the narrator's conscious awareness. Sometimes this created a false memory 
(Reyna et al., 2016). Hindsight bias might guide an interviewer in determining the difference 
between a false memory, a truthful memory, and a fabrication (Volbert & Steller, 2014). 
Douglass et al. (2013) stated false memories tended to affect eyewitness accounts of a crime. 
The authors noted that these mistakes included: (a) using questions that lead the witness; (b) 
frequent interruption of the account; (c) using closed instead of open questions; and (d) not 
listening to facts that seem unrelated to the question asked. These issues were similar to those 
raised by expert narrative researchers (Riessman, 2008; Saldaña, 2016). 
Role of Narrative Medicine in Pain Relief 
Jovchelovitch and Bauer (2000) stated that narrative research was a well-recognized 
method for documenting shared cultural experiences, particularly illness and chronic pain 
experiences. The authors felt that both the subject and the experimenter were active 
participants in creating a credible account with a beginning, middle, and end. Maxwell 
(2013) stated that surveys and case studies removed data from their original contextual 
relationships and placed them in another context, thus changing their meaning. An excellent 
way to maintain and fully understand the chronic pain experience was to put the data back 




Tsao (2012) suggested that one of the reasons for the undertreatment of persistent 
pain was that the patient's voice was missing from the treatment debate. The author stated 
that the field currently needed a deeper understanding of: (a) the consequences of medical 
decisions to restrict access to pain medications; (b) the reasons why doctors do not fully 
understand persistent, chronic pain and tended to dislike treating it; and (c) the social effects 
of long-term pain on treatment outcomes. Jurecic (2012) stated that misunderstanding a pain 
patient's experience commonly occurred in the medical literature. The author felt that this 
lack of understanding was because of the hermeneutics of suspicion. Jurecic defined 
hermeneutics as the willingness to listen but a readiness to maintain doubt. The author stated 
that illness narratives have a long history of being discounted. Also, advances in medical 
technology often created a historic distance between patient and doctor (e.g., Newton et al., 
2013). Insurance companies and the profit motive discouraged comprehensive doctor/patient 
contact and limited the ability to converse in depth (Larsen, 2016).  
Jurecic (2012) stated that misunderstanding the experience of a pain patient usually 
left patients at a loss, especially when they had a complicated medical condition. The author 
said that unanswered questions about their prognosis, sometimes not fully understood by 
anyone, created suspicion and distrust. Jurecic posited that if one could put illness narratives 
back into their previously important role in the healing process, it could rehumanize pain 
treatment. The author further asserted that narrative research gives satisfaction and complete 
the meaning of the illness experience. Jurecic also stated that narratives were a check on 
dehumanizing technological approaches to treatment. Finally, because they were accessible 




social change both in the doctor/patient relationship and for social stigmatization as a whole. 
Jurecic concluded that narrative research would add the voice of the patient and deepen our 
understanding of how pain treatment might improve. When this voice is missing, doctors 
might find themselves in the gatekeeper's role instead of their preferred role of healer 
(Carlsen & Nyborg, 2017). 
Summary and Transition 
The study of pain and pain perception has varied throughout history, mainly due to 
the lack of objective measures and the subjective nature of the experience. Nonetheless, 
research also showed that persistent pain was undeniable. In response, various conceptual 
models of pain promoted different treatments of pain, which led to controversies. According 
to some researchers, this controversy led to the undertreatment of pain, fueled by fears of 
addiction to pain medications, particularly opioids. 
These controversies led to variations in how patients in pain were perceived and 
treated by the medical community. Research also showed that the lack of an objective 
measure of pain might create circumstances where medical decisions could be affected by 
bias and stigma. The perceptions sometimes led to undertreatment, mainly due to a 
reductionist approach to chronic pain that focused on the underlying causes instead of its 
experiences.  
The theoretical frameworks of social identity theory and attribution theory were used 
to understand how bias, particularly implicit prejudice, and confirmation bias, can 
unintentionally create stigma. This stigma might prolong suffering and sometimes caused 




that to re-humanize treatment, the field needs more research that included the voice of the 
patient. Surveys and questionnaires were previous attempts to add the voice of the patient 
into the treatment process. Without the context of their reports, however, what people in 
chronic pain experienced was lost.  
Chapter 3 presents the research design and rationale, including how the narrative 
approach plays a role in the research questions. This chapter also presents my experience in 
caring for a spouse with persistent pain, its effect on my role as a researcher, and other 
trustworthiness issues. The methodology section includes the rationale for participant 
selection and my data analysis plan. The chapter ends with my procedures for complying 





Chapter 3: Research Method 
The purpose of this qualitative study was to explore the complex nature of pain 
through the narratives of people who experienced persistent, chronic pain after treatment. In 
this research, I collected stories of chronic pain, treatment-seeking, pain relief, and stigma. 
The results were narratives told in the words of the participants. By looking for common 
experiences, I attempted to develop a deeper understanding of how the participants, their 
families, and their providers might better manage chronic pain.  
Research Design and Rationale 
What was missing from the literature was a deeper understanding of how individuals 
with persistent, chronic pain experienced treatment, relief, and stigmatization. The research 
needed more information about chronic pain experiences to illuminate better ways to 
understand and treat the condition. In brief, chronic pain was considered a qualitative 
experience (Penney et al., 2016; Webster & Harden, 2013). There was a growing interest in 
using narrative analyses to rehumanize the understanding of chronic illness (Bury, 2001; 
Thomas, 2010). The research suggested that a narrative approach might address the gap in 
chronic pain understanding (Rajagopal, 2011; Tsao, 2012). 
Eaves (2015) stated that narrative research was a well-recognized method for 
documenting shared cultural experiences, particularly illness and chronic pain experiences. 
The author said that both the subject and the researcher were active participants in creating a 
credible account with a beginning, middle, and end. Eaves concluded that an excellent way to 
maintain and fully understand the chronic pain experience was to collect the data as it occurs 




Riessman (2008) stated that the stories people told themselves created social 
identities that were often fluid. The author noted that narrative research was the study of 
information that created a given outcome, meaning, or social identity. Riessman suggested 
that a narrative researcher intended to learn about an experience in all its details. The author 
added that a sequenced narration was the best approach to analyze this experience. Riessman 
believed that examining themes over multiple, independent stories makes it possible to 
identify common experiences of participants. 
Riessman (2008) further stated that a narrative method looked at the whole story and 
its themes, not just the common details broken into fragments. The author believed a 
grounded theory analysis, with coded narrative fragments, sometimes left out the context. 
Riessman added narratively organized ethnographic studies only focused on the 
interpretations of the researcher. They missed the experience of the participants and their 
surrounding culture. The author also believed that other qualitative research forms, such as 
hermeneutics, semiotics, discourse, and conversation analysis, offered some narrative 
research elements. Yet, Riessman suggested the narrative approach was more 
crossdisciplinary and gave a broader picture of the lived experience. Narrative research also 
tended to offer a more comprehensive understanding of the social identity of pain patients 
and the consequences of such an identity (Bury, 2001; Frank, 2015). 
Research Questions 
This study addressed the following research questions and subquestions to draw 
closure on the identified gap in the literature: 




SQ1a: How do these participants describe their experience of access to treatment? 
SQ1b: How do these participants describe their experience with the pain management 
process? 
RQ2: What is the meaning of stigma for participants who use or believe they need 
opioids? 
SQ2a: How is stigma experienced in the treatment process? 
SQ2b: How is stigma experienced with family and other social supports? 
Role of the Researcher 
Riessman (2008) recommended that a qualitative researcher's primary goal was to 
find recurring patterns in independent narrations without creating a bias. The author stated 
that the participants might simply give information the researcher appeared to expect in a 
poorly designed study. As a result, even though interviewers were the cocreators of the 
narrative, Riessman believed that their influence over the story content should be minimal. 
Therefore, in this study, the pain stories were in the first person and used words chosen by 
the participant. My role as the researcher was to mostly listen, clarify when necessary, 
prompt if the narrative faded prematurely, and allow for tangents. Such an approach allowed 
for analysis of the style of the story as well as its content.  
Putting an illness into a narrative may also have a beneficial effect on the participant's 
ability to cope with their pain by giving their experience more profound meaning and 
supporting a positive social identity (Thomas, 2010). Creating an empathetic narrative during 
the 4 years of caring for my spouse with refractory pain gave us both an experience of this 




manage her pain, using more biopsychosocial strategies. As her pain management strategies 
progressed, she started a garden, did regular exercises, became more involved in church and 
community activities, incorporated meditation into her daily routine, and tried to increase her 
circle of friends. Friends and medical providers often commented on her improved ability to 
manage her pain over the years. 
For the first 2 years of my wife’s pain experience, however, I felt multiple doctors 
were dismissive of the amount of pain she suffered and often left her pain undertreated. 
There were several confrontations with various doctors who described my wife as: (a) being 
an addict, (b) exaggerating her chronic pain due to mental illness, or (c) as intentionally 
malingering. Two years later, my wife’s underlying medical conditions progressed to where 
medical tests confirmed her reported pain. Also, due to my review of the pain research, I was 
better able to understand why some physicians decided to undertreat. In these discussions, I 
was able to offer research-based alternative points-of-view. After my wife received regular 
opioid medications, my conversations with prescribing doctors became less contentious, 
particularly with her primary physician. Nonetheless, it still appeared that my wife's pain 
continued to be ineffectively managed, intermittently, during numerous hospitalizations.  
In a typical hospital admission, an emergency room doctor ordered an opioid pain 
medication that adequately treated my spouse’s pain. Once admitted into a hospital bed, 
however, my spouse often called and said that the hospital physician discontinued her 
previously prescribed opioid medication with no explanation. Instead, the hospital substituted 
Tylenol and ice packs. After multiple calls and complaints, sometimes a third doctor would 




prescribed opioid was only at half of its regular dose. Still later, sometimes days later, and 
after further complaints to the hospital, the dosage would be increased to an adequate level—
but not always. The problem with this dosing approach, and its negative consequences, 
existed in research on unnecessary pain during cancer treatment (Melzack, 1990). 
Despite our best efforts, these undertreatment experiences during hospital admissions 
happened so often that my wife loathed going into a hospital. Yet, her frequent kidney 
infections, the danger of sepsis, and her numerous vertebrae compression fractures remained 
a concern. I worried that avoiding the hospital was a risky choice. The ordeal of my wife, the 
lack of definitive answers, and the conversations I had with doctors over the years, was the 
inspiration for this study. 
These experiences might raise questions about the trustworthiness of this study. The 
extensive and sometimes contentious history of caring for my wife might have created a bias 
for reaching conclusions. Roulston and Shelton (2015) gave six suggestions for managing 
bias in qualitative analysis: (a) acknowledge interests of the researcher and how it might 
influence data analysis, (b) reflect on how closely the data stays within the range of the 
research questions, (c) examine how the data elicited differences from researcher 
expectations, (d) reveal what data surprised the researcher, and (e) explain how the 
conceptualizations of the researcher changed the throughout the study. I used all these 
guidelines in my data analysis. 
I used six suggested steps to minimize other trustworthiness threats: (a) become 
involved in the phenomenon on a long-term basis; (b) develop rich, detailed data; (c) solicit 




different circumstances; (e) look for negative examples (e.g., where there was no use of 
addictive medications, yet participants managed their pain effectively); and (f) use numbers 
appropriately in qualitative research (Maxwell, 2015). Another strategy I used to minimize 
possible threats to trustworthiness was recognizing how personal experiences with the topic 
can be an attribute for qualitative researchers (Patton, 2002). Finally, in the selection of 
narrative themes, it was essential to examine multiple perspectives. These perspectives 
included: (a) participants who refused or severely limited pain medications, and (b) attempts 
to balance, complete, and fairly represent multiple points-of-view (Shenton, 2004). 
I did not use triangulation, where data collection entails different methods (Shenton, 
2004). Data came solely from the narrations of the participants, with me as the sole data 
collector. This data was available, though, both in raw and coded form, for any committee 
member to examine. To increase trustworthiness, I used member checking (Varpio, 2017). 
Feedback also was continuously solicited from doctors, other treatment professionals, 
individuals with chronic pain not in the study, and other acquaintances who showed interest. 
After I stated that I was not a medical professional during these discussions, I freely gave any 
helpful information I could offer.  
Finally, I recognized that my experiences with pain management were both an asset 
and a drawback. It was an asset because I was already deeply involved in the phenomenon. It 
was a drawback because it opened the possibility of bias. Because of trustworthiness issues, I 
addressed: (a) implementing what research suggested would minimize bias, (b) following 
suggestions from expert qualitative researchers, and (c) bringing in different points-of-view 






Participants had to meet the following criteria: (a) be 18-years-old or older, (b) be 
able to express the details of their condition, (c) be able to consent to the study, (d) respond 
to a formal invitation to participate from a referral source or approach me and volunteer, (e) 
had experienced their pain for 3 months or longer, and (f) experienced persistent, chronic 
pain daily or regularly. These criteria gave the participant adequate experience with current 
medical treatments, chronic pain limitations, and increased participant selection 
trustworthiness. 
Sampling Strategy and Criteria 
Participants came from a convenience sample those who responded positively to the 
distribution of an invitation from a “referral source” or who approached me and volunteered 
after hearing I was doing a study on chronic pain. Possible sources of referrals included: (a) 
local health vendors (e.g., health food stores); (b) sponsors of local health management 
classes; (c) acquaintances of mine who encountered people with chronic daily pain; (d) 
people with whom I had an established relationship and who knew others in chronic pain; 
and (e) snowball sampling where people I had interviewed referred others in chronic pain. 
Referral sources did not choose participants. They only forwarded invitations to their 
contacts without further influencing the choice to participate. The invitee contacted me a self-
addressed, stamped envelope (SASE) included in the referral packet. They were also able to 
contact me by phone or email to find out more about the study and to decide to participate. 




There was no attempt to limit participants who were unhappy with either their doctor 
or their treatment regimen. Neither were those participants excluded. There was a purposeful 
attempt to solicit participants from minority groups. Monsivais (2013) stated that bias was 
evident in chronic pain management. The author questioned whether minorities had increased 
difficulty seeking treatment for chronic pain.  
Sample Size and Saturation 
The number of participants was planned to be 10-15 individuals. Previous narrative 
research stated that this was where saturation tended to occur (Boddy, 2016; Francis et al., 
2010; Mason, 2010). The final sample size was 17 individuals. Saturation had two 
considerations: (a) theme saturation, where new interviews reported no new themes; and (b) 
meaning saturation, where up to nine of the most frequent themes were assessed for 
consistency of meaning (O’Reilly & Parker, 2013). If either of these criteria had shown a 
lack of saturation, I would have increased the number of participants. Since there appeared to 
be saturation, the search for participants ended. All participants received a written report 
summarizing the results.  
Instrumentation 
The semi-structured interview questions attempted to encourage the participants to 
tell their pain experiences in their own words (See Appendix B for the interview script). 
Several books influenced the selection of interview questions. These books focused on 
helping people with refractory pain organize their thoughts, understand possible treatment 
options, and consider alternative approaches to dealing with pain (Caudill, 2016; LeFort et 




During data collection, I informally interacted with other people in chronic pain and 
who showed interest in sharing their experiences with me. These informal interactions 
provided shared experiences like the formal participants, despite different diagnoses and 
circumstances. Finally, this instrument initially evolved from an attempt to meet the 
requirements of an advanced course on qualitative analysis techniques. The early version of 
this instrument produced hours of recorded data from three individuals who voluntarily 
allowed me to interview them regarding their chronic pain as part of my course assignments. 
This study did not use any of those data. 
During the interviews for this study, I inquired as to: (a) their gender, (b) age range, 
(c) reasons for chronic pain, (d) region of the country, (e) medications used, and (f) length of 
time in chronic pain. I did not ask these questions directly. Instead, I hoped the data would 
occur naturally during the narration. If they did not, these queries followed what appeared to 
be the natural end of the narrative.  
The semi-structured interview introduced enough flexibility to answer the research 
questions but kept the narrative in the subject's words. I was a skilled interviewer and 
ensured that all participants had the same interview questions. Such consistency allowed for 
better comparisons of narrations. The semi-structured interview questions did not change as 
the data taking progressed. Nonetheless, I sometimes rephrased the questions to deal with 
any context or culture-specific issues that arose during the interview. To add to the 
trustworthiness of this study, I informally interviewed doctors who treat pain. I looked for: 




the experience of chronic pain, and (c) if they would be interested in being a possible referral 
source for other participants. 
I obtained certification to teach courses on the self-management of chronic illnesses. 
These courses were through a local hospital and its patient education program (Nathan 
Littauer Hospital, 2012). Self-Management Resource Center (2018) developed the program. 
Teaching these courses gave me further experience in the field of treating chronic pain. 
Procedures for Data Collection 
The primary interviews occurred by phone through a computer conferencing website. 
Before beginning the interviews, all participants gave written consent, sent to me by the 
included SASE. The interviews took between 20 to 60 minutes. An audio recorder provided 
by the website recorded all questions and responses. This recording was then transcribed into 
a word processing file by computer through a transcribing website. I later checked the 
accuracy of the transcriptions using the tools provided by the transcription website. No one 
else had any access to the data. 
Since the interview was online, the participants chose the location for the interviews 
that provided for confidentiality and comfort. The time of the interview was by mutual 
agreement. After 17 interviews, the study reached saturation criteria, and the interviews 
ended. All participants received a summary of their narration sent for member checking. 
Data Analysis Plan 
The overall approach to data analysis followed the guidelines given in Saldaña 
(2016): (a) similarity, themes that seemed congruent with logical expectations of the research 




questions; (c) frequency, how often either kind of themes occurred; (d) sequence, the order in 
which particular recurring themes tended to occur; (e) correspondence, how often the themes 
tended to occur with other kinds of everyday life events; and (f) causation, where the 
emergence of one theme seemed to cause another. As data emerged, they were both hand-
coded and coded by a computer program. The themes of the second and third analyses 
answer the research questions. Also included were results from discrepant cases. The 
CAQDAS software chosen for this analysis was MAXQDA (Saillard, 2011). Data analysis 
was reviewable, both in its raw and coded form, by any committee member.  
Issues of Trustworthiness 
This study addressed trustworthiness by following the recommendations of Saldaña 
(2016): (a) increased credibility using prolonged contact, saturation, reflexivity, and peer 
review; (b) increased transferability with detailed, thick descriptions and using a variety of 
referral sources to distribute invitations to enhance variation in participant selection; (c) 
while not using triangulation, I used member checking; (d) a detailed process of the study 
allowed future researchers to repeat the study; and (e) increased confirmability by using the 
words of the informants when identifying themes and making conclusions. As stated above, 
the data, both raw and coded, were saved and were available for any committee member 
review.  
Ethical Procedures 
All data were kept confidential. Identifying information was stripped from the 
narrative. I was not in a power relationship with any possible participant because I was 




came from family, friends, and acquaintances. All these participants experienced persistent 
pain and responded to a request from a referral source or approached me and volunteered to 
be part of the study once they heard about it. I kept confidentiality from other acquaintances 
and family members unless I had written permission to share the interview information. As 
stated above, I stripped all identifying information from the narrative and gave each narrative 
an identifying number. I kept all confidential information on my computer with restricted 
access, and I kept paper records in a locked box file in my home office. These data will be 
stored safely for the next five years. 
There were no external organizations that needed IRB approval to interview 
participants. Written consent was reviewed and signed before the interview began. After they 
signed, each participant received a copy of the consent agreement. If any participant was 
reluctant after giving initial consent or expressed a reluctance to continue, I took the first no 
as an answer. The results reflected the number of participants not completing the application. 
Any information gathered to that point was eliminated from the final analysis. 
Participants experiencing persistent, chronic pain were from a vulnerable population. 
Interviews certainly involved sensitive topics. High priorities included earning the subject's 
trust, assuring confidentiality, and developing a nonjudgmental, empathic connection. The 
approach helped participants develop a deeper understanding of their situation and learn 
better-coping skills (Charon, 2001). If an interview produced distress in any subject, I would 
have referred the participant to a trained clinician or other support sources. This resource was 




Summary and Transition 
This study explored the complex nature of pain through the narratives of people who 
experienced chronic pain after treatment. I addressed my experiences with caring for a 
spouse in chronic pain and its possible effects on the study's results. The target group was 
adults who experience persistent, chronic pain daily, or almost daily, for three months or 
longer. An online audio recorder website recorded the entire interview and protected 
confidentiality. A second online service transcribed all audio recordings into word processing 
files. Using the tools of this second website, I checked those files against the audio recording. 
The number of participants was 17 individuals. I obtained written consent for other ethical 
concerns, kept all data confidential, stripped identifying information from the narrative. 
In the following chapter, I describe the participant pool and the procedures for 
analyzing the data. The results are presented and organized by research question. Discrepant 





Chapter 4: Results 
The purpose of this qualitative study was to explore the complex nature of pain 
through the narratives of participants who experienced chronic pain and received varied 
treatments for it. This exploration collected participant stories of chronic pain, treatment-
seeking, pain relief, and the experience of stigma. There was a growing interest in using 
narrative analysis to rehumanize the understanding of chronic illness (Bury, 2001; Thomas, 
2010). Prior research revealed that patients' voices were missing from the literature, and 
narrative research was an excellent way to gain access to these to better understand chronic 
pain (Eaves, 2015; Rajagopal, 2011; Tsao, 2012).  
This study addressed the following research questions and subquestions: 
RQ1: What are the narratives of chronic pain management in patients? 
SQ1a: How do these participants describe their experience of access to treatment? 
SQ1b: How do these participants describe their experience with the pain management 
process? 
RQ2: What is the meaning of stigma for participants who use or believe they need 
opioids? 
SQ2a: How is stigma experienced in the treatment process? 
SQ2b: How is stigma experienced with family and other social supports? 
For the study I used two different methods to analyze the results. One was a structural 
analysis that grouped participants according to the strategies they used to manage pain. The 
second analysis examined how the results addressed the research questions and themes that 




details how I collected and analyzed the data. Finally, how I systematically explored the 
themes that resulted from those analyses. 
Settings 
The primary interviews were by phone through a computer conferencing website. I 
used website tools to record and transcribe all interviews. As promised, no one besides me 
had any access to the raw data. The participants chose the location for the interviews based 
on their sense of confidentiality and comfort. The time of the interview was by mutual 
agreement. After 17 interviews, the study reached saturation and the interviews ended. 
Because the last four interviews produced no new themes or experiences, this met the 
requirement for saturation (O’Reilly & Parker, 2013).  
There were a few problems with the member check. The member check plan was to 
summarize the interviews and write the synopsis in the third person. All identifying details 
were eliminated or changed, as planned. However, the COVID-19 pandemic posed a few 
problems with sending the summaries to the participants. The first attempt was to email a 
password-word protected file to each participant. Most participants could not open this file 
even after they received the password. The modified member check plan sent each 
participant a printed file created using pandemic-safe protocols of a mask, gloves, and tape to 
seal the envelope. This modification delayed the final data analysis, but participants who 






Of the 17 participants, 10 were women, and seven were men. Because the interviews 
were by phone, there were no restrictions on location, a possible concern before the study 
began. All participants were American citizens. All were Caucasian, but three were born in 
Lebanon. Eleven participants lived in my local area, Gloversville, NY. There were two 
participants from the Northeast. Finally, there were four participants from the Southeast and 
one participant from the Southwest. As described in Chapter 3, my intent was to recruit 
participants from my geographic area. Yet, in the final sample, six participants were 
nonlocal. Table 1 displays the age range, diagnosis, and primary means of managing pain for 






Demographic Characteristics of the Sample 
 
Pain group Participant Gender Age Range Diagnosis 
Pain gone       
 
Ralph male 65-74 years Herniated disc back/neck 
 
Peter male 25-34 years Torn ACL 
Nonopioid 
   
 
Justin male 18-24 years Back pain 
 
Bill male 45-34 years Back/knee pain 
 
Ada female 25-34 years degenerative spine 
 
Sally female 65-74 years Cyst at the base of the spine 
 
Vito male 25-34 years Ehlers-Danlos syndrome/arthritis 
 
Mada female 25-34 years Kidney Transplant 
 
Rita female 65-74 years Neck/leg pain 
 
Dina female 55-64 years Shoulder dislocated 
 
Jean male 65-74 years Spinal stenosis bone spurs/bulging 
disk  
Rachael female 74-85 years Arthritis 
 
Caity female 65-74 years Stenosis in the spine 
 




Ben male 45-54 years Degenerative bone disorder 
 
George male 35-44 years Kidney transplant/arthritis 
 






The target group was adults who were: (a) 18-years-old or older, (b) could express the 
details of their condition, (c) were able to consent to the study, (d) had experienced their pain 
for 3 months or longer, and (e) experienced persistent, chronic pain daily or regularly. These 
criteria gave participants adequate experience with current medical treatments, and chronic 
pain limitations and insured trustworthiness in participant selection. 
As previously stated, most participants came from a purposeful sampling of adults 
who responded positively to the distribution of an invitation from a referral source. Also, 
some participants came from people who volunteered after hearing about the study. 
Furthermore, a few participants came from snowball sampling of those interviewed. All 
participants then contacted me to answer any questions, signed the necessary consents, and 
made an interview appointment.   
The original data collection protocol was modified when people who heard me speak 
about this study approached me and asked if they could participate. The original data 
collection plan did not anticipate such a qualification for participation. The modified data 
collection protocol added this qualification after IRB approval (Walden University IRB 
approval number 04-19-19-0116261). Once individuals qualified, the interview protocol 
went as planned. Eleven people handed out invitations and were not participants. These 
referral agents distributed over 75 invitations. Of the people who received invitations, 15 
people responded positively, and five others approached me after hearing about the study. Of 
those interviewed, five participants agreed to contact other people they knew who were in 




In every referral packet, there was a letter describing the study, Of the 20 people who 
filled out the necessary paperwork, 17 set up an interview appointment, and three did not.   
While I had not anticipated that some participants would be pain-free at the time of 
their interview, it did not disqualify them from the study if they were previously in pain for 3 
months or more. Two participants reported they were pain-free. Concerns of a study 
limitation due to limited medical services in my surrounding community were unfounded. 
Participants included individuals from other parts of the country (see Table 1). Some 
received advanced treatments specialized for their diagnosis and were provided pain 
management treatments not available in my local community. 
The semistructured interview protocol did not vary for any participant. After 
expressing interest and signing the consent, every participant received a phone contact that 
answered any questions and set a time for the interview. A computer conferencing agency 
recorded phone conversations. Afterward, an online service transcribed the data using 
computer algorithms into a word processing file. I then used the tools at the transcription site 
to check the transcriptions against the audio. As a result, I was the only person who had 
access to any form of raw interview data. 
Structural and Thematic Analysis  
I used two different approaches to analyze these data. I used a structural analysis to 
explore the difference between three groups: (a) participants who were pain-free at the time 
of the interview, (b) participants who had chronic pain but did not use addictive medications, 




thematic analysis answered the research questions by exploring common themes discovered 
through computer-assisted qualitative data analysis software. 
Structural Analysis 
I first analyzed all transcripts through a structural analysis by hand from the 
transcribed interview data. The resulting documents were chronological pain stories for each 
participant. The results of the structural analysis revealed the narrative organization of all 
pain stories. Each had a beginning, middle, and end. This analysis revealed that, while there 
were numerous similarities among narratives, the experience of chronic pain was 
idiosyncratic but was able to be grouped by the way the participant chose to manage their 
pain: 
 Pain free. Participants who experienced chronic pain for 3 months or more, but 
the pain had resolved. 
 Nonopioid pain management. Participants who did not use opioids or addictive 
pain medications regularly. 
 Used opioids or other addictive medications. Participants who used opioids or an 
addictive medication as their primary pain management strategy. 
The resulting structural differences are in Table 2. Later, these documents were the 





Table 2  
Participant Differences in Their Primary Pain Management Strategy 
 




   
Access to 
treatment 
Had little trouble 
accessing treatment. 
Had some trouble 
accessing treatment. 
Remained worried 
about access to 
treatment  
Managing the 
ebb and flow of 
chronic pain 
 
Typical ebb and flow 
pain management 
Ebb and flow of pain 
difficult on some 
days 




Did not have a 
discussion about 




addiction with a 
doctor 
Felt they had to prove 
they were not an 
addict when with a 
doctor  
Use of opioids Avoided opioids and 
other addictive drugs 
Avoided opioids and 
other addictive drugs 
Embraced opioids and 





always led to 
addiction 
Believed opioids 
always led to 
addiction 
Believed opioids 








stigma after being 
pain-free. 
Experienced some 
stigma from medical 
professional 
Experienced major 






stigma from others 
after being pain-free. 
Experienced some 
stigma from family 
and friends 
Experienced major 






The results of this analysis also revealed fundamental structures that affected: (a) 
access to treatment, (b) daily planning to manage pain, (c) how often they experienced stigma 
from doctors, and (d) how often discussions about addiction arose during medical 
appointments. The most dramatic differences were in the group who used opioids or another 
potentially addictive medication to control pain. These differences are described below and 
supported with text from participant transcripts.  
Access to Treatment 
Access to treatment for chronic pain varied according to the primary way participants 
managed their chronic pain: 
Pain-Free 
The following participants who had resolved their chronic pain seemed to have little 
difficulty accessing medical treatment. Peter said, 
I did go to doctors and orthopedists. I went … several times to orthopedists. I … got a 
prescription every time for physical therapy. I also … brought up Active Release…. 
My doctor … said she had heard of it. And that was really helpful. 
 Ralph said, “I go see my family practitioner. He checks up on me…. I got blood pressure 
and cholesterol problems.”  
Non-Opioid Pain Management.  
Some participants who used OTC medications and other strategies to manage pain 





Because I was terribly under impressed [with my treatment]. It was not helpful. I 
thought it might have been sciatica. They said it wasn't. They didn't really tell me 
what it was. They didn't seem to know what it was. I went to the pain clinic, initially, 
I saw one doctor. Then they had made up a follow-up appointment. And he, all of a 
sudden, had quit and I saw somebody else. And then that person left. They did 
recommend physical therapy. So … I went back. I went to PT. And they did various 
exercises for probably a couple of months, maybe … two to three months. And it 
didn't do one single thing … it didn't seem to have any rhyme or reason to it. And I 
would do the PT and it wouldn't have any kind of an impact, whether I did it or not. 
So, after a couple months … I just told them it's not making a difference. It's not 
doing anything. It doesn't seem to make one bit of impact … So, I stopped going.  
Sally said, 
And people thought it was sciatica, but it was not sciatica. So, I was going to 
physicians to try to get a diagnosis. I went to an orthopedic [doctor] and I went to a 
chiropractor to try to deal with it. And I finally ended up at a neurosurgeon's office. 
And he was the physician who was able to help me the most, at least, in diagnosing 
what I had. Through all the tests, through the years, I had MRIs. And they showed a 
huge cyst in the base of my spine. It was, I think, 3 centimeters long, or something 
like that, in size. And what the neurosurgeon said, because he did a contrast MRI … 
[was] that [the] cyst is leaning on nerves in the base of my spine. And it's developed a 




Used Opioids or Other Addictive Medications 
Participants who used opioids regularly were apprehensive that their next doctor visit 
might result in losing their most effective pain medications. Mary said, 
She’s a PA and when I asked for a refill of the Soma [Carisoprodol], the head doctor 
in the practice put a note in my chart, “Get her off of this…. She should not be taking 
that all the time.” And I panicked and I said … what am I going to do? I do not take it 
for pain management, I take it for my bladder. So, she [my PA] advocated for me. 
George commented, 
I mean, they did do the tests, but when things were coming back negative, they sent 
me to a rheumatologist. But my blood tests were coming back almost negative. I 
didn't have … arthritis. But they said it wasn't what was causing my issues. But again, 
they didn't know really what to do because pain management as a thing wasn't really 
popular. And every time we mentioned it, [the] docs … [said] “No, no, no. You got to 
go see a specialist.” But never point me in the right direction.  
Managing the Ebb and Flow of Chronic Pain 
All participants had to manage both mild pain days and days that were more difficult. 
However, the intensity and frequency of these experiences varied according to the primary 
strategy used to manage chronic pain. 
Pain Free 





I have like soreness after working out, but it's within normal limits. So, right now my 
pain is no worse than it was before my injury because I have a flat foot on my left 
foot. And that's always had some soreness to it. But it hasn't really been a problem 
ever. It was pain within normal limits for what I was used too.  
Ralph stated, “The first episode of pain, with all those pills, was gone by … September 25th, 
1998. I'll never forget it…. That's 21 years ago…. And four years after that … I was 
[ultimately] without pain.” 
Non-Opioid Pain Management:  
For participants who use OTC medications as their primary medical intervention, 
there were difficult days and some more easily managed. Rita said, 
It hurts every day. But sometimes it tends to be worse. Sometimes when I'm sitting at 
the computer working … I … take an Excedrin…. Or I might have to lay down if my 
back is in spasm for a little while … or to put heat on it. [Yet] I do the same things, 
whether I'm in pain or not. And it doesn't stop me from doing any activities. But … 
sometimes I just have to sit and rest. And … occasionally go out and do things. But 
what really starts to bother me is … in the evening, when I'm watching my 
granddaughters. 
Rachel stated, 
I know when I start hurting that I just have to take more breaks. I have to sit down in 
between while I'm doing outdoor work or whatever I'm doing and kind of relax. And 




back to try to finish the job if I can. Whether it's mowing or trimming or painting or 
whatever I'm doing or washing floors or whatever. 
Mada said,  
The only medication I can take is Tylenol. Well, no matter what happens, even if I 
got sick, like now, I'm not allowed to get out of the house a lot because my immune 
system is very weak…. So maybe the pain is less [since my liver transplant] it's like 
80% less. But the pain in my kidney now, sometimes it's crazy because it starts from 
that from the lower back all the way to the shoulder…. So, it's going to be a bumpy 
road. But I'm going to be strong enough for it. I passed through a lot of pain. I'm 
learning to pass through more if I actually get to a point where I'm going to be 
painless, completely painless.   
Used Opioids or Other Addictive Medications 
For participants who used opioids or other addictive medications, difficult days 
appeared to be more likely and more frequent. George said, 
So, when I wake up in the morning, that's usually when it's at its peak. Because I've 
been lying down and sleeping. And I wake up and everything is just hitting me at 
once. Just getting out of bed is like a job…. Sometimes … it's not worth it…. I'm just 
going to call in…. As soon as I get up and move, and I start moving the joints a little 
bit, I have to get hot water on me immediately…. I am almost in tears sometimes 
because it's so bad. I run my hands … [under] hot water so those things start 
moving…. I get in the shower … [and] let all the heat do what it's got to do. And then 




once. I'll take some medicine in the morning. I'll finally get to work…. then once my 
pills start kicking in … it takes the edge off just enough so I can function. It's not that 
the pain disappears. It gets to the point where I could actually do my job without 
really showing them I'm [in] a little bit in pain.  
Ben stated, 
In a lot of pain? Well, it's pretty much every day that I come home from work … I 
come home … my hips are sore. It's hard to fall asleep because I can't sleep on my 
back. I don't sleep on my stomach. So, I kind of jump from side-to-side and my hips 
are always sore. Feels like I got hit with a baseball bat, sometimes. And this is very 
uncomfortable.  
Discussion About Addiction with Doctors 
While addiction was a concern for all participants, it most often became an issue 
during a medical appointment if the participants were using an addictive medication to 
manage their pain. 
Pain-Free 
Doctors sometimes offered addictive medications to participants during their time 
with chronic pain. One participant used them, but neither participant felt they were useful. In 
response to a question if he had ever had a conversation with any doctor about addiction, 





The last doctor I saw [while I was in pain] … told me there was nothing he could do 
for me except for keep giving me pain pills. I said they're not working. They just said, 
well, there's nothing we can do. 
Non-Opioid Pain Management 
Even when participants refused addictive medications, they still had to deal with the 
possibility that they were secretly harboring a desire for an addictive drug. Dina said, 
Yes, they dismiss what I'm actually telling them because they think I'm only there 
looking for them to give me a pill--until I got really upset. Like I didn't even ask for a 
pill. And in prior years, in another instance, I went to a neurosurgeon and he said to 
me, “We don't write pain pill prescriptions.” And it was the first time meeting him. 
And truly, what he said to me was very offensive. Because I never asked him for a 
pain pill, never implied I wanted one. And he directly looked at me and told me that. 
Like he thought that's what I was there for. 
In response to a question as to whether he ever had a conversation with any of his doctors 
about addiction, Justin stated, “Yes. Usually, depending on like the medications that they 
prescribed. Just … [be] careful on how much you take or whatever … because certain 
medicines can be very addicting compared to others.” When it was suggested that he did not 
take them, he replied, “That was the hydros [hydrocodone].”  
Used Opioids or Other Addictive Medications 
When participants used additive medications to control their pain, they often had to 




So now I am to get this young doctor. Now I've got to sit here and tell my whole story 
again and they don't like giving medicine … because everybody's acting like … 
there's a bigger epidemic or something. You know, they don't want to give anybody 
any pain medicine anymore. And it's like you've got to be kidding me. You don't 
know my story. The only thing you see is that there's a chart saying, hey, he's been on 
this medicine a long time. Why is he on this medicine? 
George said, 
But every time I got a new doctor and they saw [Dilaudid] it raised red flags on their 
end ... they immediately … say, “Let's get you off of this.” And I'm … looking at 
them saying, that's not going to work. We've done this before…. And doctors are very 
scared to write a prescription for that type of med. And I mean, I understand, but 
when you get a person that's on it for a reason, there's a difference.  
Believed More Medical Intervention Would Help 
Even when participants had a bad experience with doctors when managing their 
chronic pain, a strong faith in medical interventions remained, for the most part. With 
participants who used addictive medications, however, their faith usually contained a dose of 
skepticism.  
Pain Free 
Pain-free participants had positive things to say about medical intervention. Peter 
said, 
[My doctor] was pretty validating. I felt like she was letting me know that she was 




trained. Her background was in sports medicine. And she knew a lot of people who 
got surgery and people who didn't get surgery. 
Nonopioid Pain Management 
Despite having some difficult experiences with chronic pain and doctors, participants 
in this group maintained their faith in medical interventions. Sally said, “I go to the doctor for 
my annual physical…. And so, I'm sure that he would order pain medication for me, but I 
have not asked for it.” Caity stated, “I go to a fabulous [doctor] group…. So, I went there and 
… when I walked in, he said, ‘Well, I can tell you right away what you have.’ My experience 
with that doctor was just phenomenal.” Vito said, “My doctor was a really good doctor, and 
she worked at the [nearby clinic] ... I buy … [OTC medicines] at the store. Bill stated, “I 
haven't had a bad experience with a doctor. Other people have had bad experiences with 
doctors. But I've always been fortunate. My family has also been very fortunate not to have 
really negative experiences.” Ada said, 
But I really think I am lucky, and I'm blessed that at least for the conditions I have are 
treatable. Worst case scenario was the surgery. Of course, it gets irritating here and 
there. Like, the days when the pain is really bad. But I'm so thankful because I really 
think it could be worse. And I remain motivated to do my part, to do what I can to 
prolong whatever it is that's degenerating my spine. We'll find that out soon, 
hopefully. And I'll do my part, as much as I can, like I said, and the doctors will do… 
theirs. I've seen a lot of doctors, in different states and different countries, try[ing] to 
get as many opinions as I can. And, recently, I kind of realize that they all have the 




Used Opioids or Other Addictive Medications 
Participants in this group liked their doctors but seemed worried about the future 
treatment of their chronic pain or a change in provider. Ben stated, 
I'll be meeting my new doctor and I don't know how keen they are to giving me pain 
medicine … he did run bunch of tests and, [made] sure that I'm taking my medicine 
and … not abusing them … and I tested out fine…. And it's kind of scary, at the same 
token … because what I [was] used too … [was] a great doctor. He even told me 
things like, “I'm an old school doctor…. I know what it's like to be a laborer.” He 
knows how many surgeries I've been through.  
Mary said, 
I had to have the battery replaced [in my spinal column stimulator] but … things 
didn’t work right, so they ended up doing the whole thing over. So, that one lasted 
until the battery ran out in May of 2009. Then it was replaced, and it’s been a miracle 
until last year when I felt my whole back of my shoulder and my ribs was burning 
and on fire ... they told me I had a broken rib, they told me I had shingles … and 
finally, last December, I convinced them to do a myelogram … and it showed that the 
implant had shifted…. So, I had to wait to get that approved. In February, they 
replaced … [and] they revised it … and I begged them, please, the battery has already 
outlasted its lifetime, it’s going to die. And they said, no we are not going to do it. 
Well, two days after I got home, the battery died. So, I had to go back May 2nd and 
have the battery replaced. So … they think they know everything about it, and they 





 I was hoping a different doctor would say or do something different. And the general 
practice doctors, of course, [said] they don't know, but they pointed me in a direction. 
Usually starts as rheumatology first … but when I get there, I talk to the 
rheumatologist and they say, no, you need to see a pain specialist. Well, the military 
works in mysterious ways. It takes months … to get into the doctor. And when you 
finally do get there, it starts all over again. The pain doctors even went, “Well, let's 
try to see if it's a rheumatology thing.” But they don't listen to you. So, it's like a giant 
circle. That tells me either they don't know about it or they didn't care. 
Believed Addictive Medications Always Led to Addiction 
Participants who were not using addictive medications did not state that they felt the 
need for those medications. Some reported that they would refuse if offered. Participants 
using addictive medications, however, felt that their medications were essential.  
Pain Free 
Pain-free participants believed that potentially addictive pain medications should be 
avoided and usually led to addiction. Peter said, “I've never smoked marijuana in my life. I 
know I get stomach trouble when I drink alcohol. So, I think I was fine with meditation 
because that's the healthy way to get a buzz for me, not for everyone.” Ralph said, 
There were times that I thought maybe I would double dose, but I wasn't that type of 
person. Even though I was in pain, they told me I had to take one tablet every six 
hours and that's what I took. I would just have to suffer if it didn't work because I 




these new drugs that they got out there, it doesn't take long to get an addiction to 
them. And then you go through some major side effects. And I didn't want to do that.   
Nonopioid Pain Management 
It was a similar reaction with participants who used OTC medications to manage 
pain. Rachael said, 
[Interviewer asked, “And do they [doctors] ever talk about other meds you could 
take?”] No. Not really. Just the basic ones as you need them. That's all. Nothing 
strong. [Interviewer, “They don't talk about any stronger meds?”] No. No. And that's 
okay because I to go the natural way. Or, like now, the biggest thing is the CBD, the 
rub. I have the rub, and I have the drops. I have to take them every day. 
Dina said, 
And I opted to not take them [Percocet] because I didn't want to cause another issue 
for myself. So, I didn't take … [as much] from the second day after the surgery. I 
didn't take them regularly … And then I would only take one a day, or one in the 
evening when I tried to sleep. Or when I really couldn't stand it, I would take one. 
Probably not even every day, but just at the point from not being able to stand the 
pain.  
Sally said, 
He was the one that offered me pain medication. He said it's just … going to be there. 
If you want and I'll give you pain medications. I said, no, I don't want it … He offered 
me gabapentin … Not any of the opioids or anything like that. [Interviewer asked, “If 




Used Opioids or Other Addictive Medications 
Participants using opioids and other addictive medication believed the drugs were 
essential to their pain management. There was also no indication of abuse. Mary said, 
After the head doctor said to stop prescribing addictive medication, my PA talked to 
him and said, “Listen, this girl needs this. She’s not taking it for pain management. 
She is taking it for her bladder because she is allergic to everything.” So, she 
advocated for me. And I was afraid [I’d] have [to] switch doctors because the doctor I 
was going to left. And…[once] they put me in [another] practice [and they] said, “I’m 
not giving you this Altram. You’re a drug addict and you need to … take pain 
management and get off of it.” I switched doctors. 
George said, 
And so, they said they put in my records for a pain management-type thing, that 
[Dilaudid] is the only thing that would work. But like I said, it's not that I got 
suggested to a pain management specialist. It was, “Let's try things to see what 
works.” And that was like [the] E.R. doctors … every time I got brought into the 
emergency room for something. It just became a routine. I had like, they call it a 
cocktail. It's just like different types of little meds. And then they give me the big 
juice med, that's what I call it … And sometimes it was a full … juice-wise, which is 
straight in [intravenous injection]. So, it immediately it takes effect, all the way up to 
2 milligrams … I did not take Dilaudid today. Like I said, on good days, I'm able to 
take … Tylenol, about a thousand milligrams…. It's not that I don't. They were 




every six to eight months I got refills. And, you know, it got down to the point where 
I was taking only so many meds or so many times, they knew I was not one of those 
[addicts]. 
Stigma from Doctors and Medical Professionals 
Stigma during medical treatments was common, but the experience varied by the 
strategy the participant used to manage chronic pain. Twelve participants experienced stigma 
during medical treatments. As will be seen, even when stigma was not experienced during 
medical appointments, all participants in chronic pain experienced stigma from some source. 
Pain Free 
Participants who were pain-free experienced stigma as a problematic memory. Peter 
said, 
Yeah, my orthopedist said that I should be running. This was the first one I saw in 
2016. And he said I should be running after I got like the boot. And … he said … 
Your leg is strong. You should be running in like three months.” And I think that was 
a very unhelpful comment. Even though I respect his expertise, he definitely was 
helpful in a lot of ways. But this … was unhelpful. And, when I thought I should be 
running in the summer later, I injured myself. So, it was not solution focused.  
Nonopioid Pain Management:  
Stigma occurred even when a participant would refuse addictive medications. Dina 
said,  
[One doctor] basically dismissed my pain when I was telling them what I felt and the 




dislocations like whew, that's nothing. What are you worried about?” And I assured 
him that if I was not in pain I wouldn't be there. 
Caity said, 
[The doctor said,] “You know maybe I'll send it to [another doctor] and let him 
evaluate.” And then he said, “Why aren't you fat?” And I said, “I beg your pardon?” 
He said, “Ninety-nine percent of the people who come in here with knee problems are 
fat.” And I said, “Well, I suppose I'm not fat because I eat right and exercise. But, you 
know, injuries are caused by all sorts of things.” 
Mada said, 
And [the case manager] said, “We know that there's something wrong with you. But 
it's not to that [much of an] extent. There's a lot of people more sick than you.” And 
… and she did not put herself in my shoes. And I actually told the doctor …. Even if I 
wasn't in pain, she should take it into consideration. [My test] results were scary. My 
liver started forming very bad cells. They were scared of cancer…. And I used to go 
nuts [when anyone mentioned I was not sick enough].  
Used Opioids or Other Addictive Medications 
Participants who used addictive medications were most likely to experience stigma 
during medical appointments and had the most to lose. Mary said,  
I have been called a doctor hopper because I kept trying to find someone to help me. 
And it is just, there very few doctors that I trust. I feel better now than I have in a 





Ben said,  
I did have a doctor visit with an on-call doctor, the one who was covering for my 
doctor. I had a different procedure done and he started giving me the business about 
me being on my medicine for so long. He's like, "Oh, you shouldn't be on it…. You 
know you should go see an orthopedic doctor.” And I'm like, “Dude you don't know 
anything about me…. you know, I don't drink. I don't do anything. I pretty much just 
take my meds and that's it. You know I'm a laborer. I've worked hard all my life. I 
still have one leg longer than the other. And I'm in constant pain.” And he just wasn't 
even trying to hear me …  and I'm like, well I'm glad he's not my permanent doctor. 
Stigma From Family and Friends 
Even when stigma was not reported from medical professions, all participants 
reported experiencing stigma from other sources. These sources included family, friends, and 
casual acquaintances.  
Pain-Free 
Again, when pain-free, stigma from friends and family were often just a bad memory. 
Peter said, 
In terms of my friends, a lot of them didn't necessarily wait up when I was trying to 
come along with them to class. And I didn't really complain about pain with friends 
so much. But I did complain about pain when I was with family. And they wanted to 
do something, and I wanted to rest. Like my parents don't take themselves too 
seriously but they do like to hurry a lot…. I don't exactly remember what he said. I 




was feeling burdened … And one of the issues was that I was taking breaks when I 
was doing well. Whenever I walked somewhere … I would sit for like maybe 30 to 
60 seconds. 
Non-Opioid Pain Management 
In this group, stigma from friends and family could be avoided by merely hiding pain 
or refusing to discuss it. Bill said, 
But it's very aggravating … because as soon as I take Tylenol, one of my coworkers 
at work … [begin] joking about it, because I was having a lot of pain. And we’re 
allowed to sleep at work when we don't have any calls because … the ambulance 
service … and the trucks are all taken care of…. So, I'm like, “Yes, this will take 
about 15-30 minutes and then I might try and fall asleep.” So [a coworker] had to 
joke it … "Oh, yeah … here's Bill. He'll take some of this Tylenol in 30 mins and 
fake snoring sounds.” Pretending like, as soon as the medicine gets in my mouth, I'm 
out like a light.  
Caity said, 
When I was 24-years-old, I had been married for six months, [and] we were cross-
country skiing with a group. And I was staying with this horrible husband that I 
divorced way too late, and I should have done it sooner. And my feet just went out. 
And I put my hand down and catch myself. And when I got up, I said I thought … I 
broke my arm. And he [husband] said, “You can't have broken your arm. You just put 
it down in soft snow.” I said, “Honestly, I think I broke my arm….” My husband was 




And then if not, we'll go home.” So, he had a beer and I said, “You know … honest to 
God, I broke my arm.” And he said, “You can't [have]. But if you're gonna be a 
booboo, we'll go home.” So, I went home and I cooked … and served dinner and 
washed the dishes and complained about my arm. And [he said] “So … since you're 
complaining all the time, I will take you to the hospital….”. So, we got to the 
hospital. They said, “You did indeed break your arm. But it's more complicated than 
that. You need to see an orthopedic surgeon….” Of course, the orthopedic surgeon 
was closed on Monday. So, I saw him on Tuesday. And he went apoplectic because I 
had a bone tumor and it had eaten my bone away … And, because I broke it, it 
pierced the tumor. If the tumor was malignant, I was in deep … trouble. Especially 
since it had been now a day and a half…. And I saw a specialist in these sorts of 
tumors…. And he said he couldn't believe I had no pain leading up to it…. Well, 
everybody has advice. Everybody has a doctor. Everybody has, “You know, what I 
did?” Everybody has an authority of some sort. And some of that's comforting. And 
some of that's just like eye-rolling….  
Used Opioids or Other Addictive Medications 
In this group, attempts to protect their most effective pain medication was to deal 
with the appearance of an addict and sometimes hide their pain. Yet hiding their chronic pain 
was often difficult. George said, 
Sometimes my friends here at work think it's fake, that I'm trying to get out of 
stuff…. I've had … people pulling me aside, saying … that I'm a shammer and I just 




go home. So, we call them shammers. [Interviewer … how did that make you feel?] 
Well, mainly angry because of my history with the military. I've never been that 
person…. But also freaked out that I'd be labeled [with] higher-ups with military 
promotions, awards, things like that. Because … you do so much in your career, all 
of a sudden, you're labeled as a shammer.  
Ben said, 
My friends understood it [but] my family maybe not so much. Everybody had the 
attitude that well you had the surgery you should be fixed you shouldn't have any 
pain. And … that's not true … they don't live with it. They don't understand … 
you're constantly walking crooked…. My family just didn't get it. They didn't 
understand…. “Why are you in pain?” And I'm like, “Well … I don't know. Maybe 
because I was cut open so many times….” I had to work for a living and 
unfortunately hard labor is hard labor…. And then having a disability definitely 
didn't help.  
Discrepant Cases and Findings 
Despite the many underlying similarities, confirmability was evident because there 
were also striking counterexamples not anticipated by the research questions. These included 
faith healing and chronic pain unexpectedly vanishing and then returning. Ralph said, 
I believe in Jesus and my brother Phil. He was a born-again Christian who was a 
Baptist minister he laid his hands on me and asked Jesus to take away my pain and 




to do things I wasn't able to do before…. [Now] I come home and I sit down, eat 
dinner, and sit and watch TV and I'm normal. I've been normal now for 10 years.  
Rita said, 
And then at some point, it [the pain] kind of just disappeared. Now, once in a while, it 
will recur, but it's much more mild … actually this winter, it kind of recurred, but it's 
much more mild and it doesn't really bother me very much. 
Thematic Analysis 
A thematic analysis was employed to explore common experiences across interviews. 
This thematic analysis used both a hand analysis and MAXQDA (Saillard, 2011). The 
themes discovered through this second analysis answered the research questions. These 





Summary of Themes for Research Questions 
Theme Example Quote 
Research Question 1 
Good pain days. A good day would be I wake up and it feels good and… I'm very motivated… 
(Dina) 
Difficult pain days. So, I did go through to the hospital. I was hospitalized for two weeks because I 
have jaundice and chronic hepatitis…. (Mada) 
RQ 1, Subquestion 1a 
Multiple Doctors and 
Uneven Outcomes 
But I just feel like they've always said there really was nothing that… they 
could do. So, I don't even bother with it anymore. I don't even bother discussing 
it. I just figured, what are they going to tell me? Ice and take pills… and I 
already know that. (Jean) 
RQ 1, Subquestion 1b 
Very Severe Pain It's [when] I have to take something for the pain. I would have to put … cold 
and hot compression on my neck. It depends on how bad the pain is. But at 
times it's so bad, I mean, I cannot even hear anything. That's how bad the pain 
gets. And other times … I just have to do breathing and stretching. And I try to 
do a lot of mind over matter. (Ada) 
Anxiety and Pain I was a constant, stressed-out mess. And I have subsequently learned that 
complicates every physical thing I have .… And I was sad about that … but my 




I was having a lot of pain. I was still trying to … do things that help me like 
remain satisfied with my life. Like I was meditating daily and that seemed to 
help. I was still doing pretty well in school. I think I actually was very involved 
with school because it was a good distraction from my anxiety about like 
reinjury and pain. (Peter) 
Research Question 2 
Social Identity and 
Liminality 
But a lot of times they just said it was not a real thing. It's in my head. Or I was 
a hypochondriac. Or, you know, we can't find any physical thing that caused 
this pain. So, it's not a real thing …. (Geroge) 
Evidence of Resilience One time, a couple of years ago, when I was having that hip issue and I was 
going to go horseback riding. And my one relatives … who tends to be 
negative, said, “Don't go. Maybe you shouldn't go.” And I said, “No way. I'm 
going to go. I don't care. It hurts anyway. I might as well go and have fun.” 
Which I did…. I had a blast and it was fine. (Rita) 
RQ2 Subquestion 2a 
Stigma from Medical 
Professionals 
“Are you visiting your psychiatrist recently?” Because I have a psychiatrist. 
“No … I'm just telling you that I'm in pain, and you guys have to do something 
about it….” Because I felt like they were taking it in such an easy way. (Mada) 
RQ 2 Subquestion 2b 
Stigma from Family 
and Friends 
Of course, that hurts because everyone keeps teasing me about I need to go in 
bubble wrap and stuff. They don’t understand…. I haven’t done any of this stuff 
on purpose. I didn’t have plans to hurt my back in nursing [school]…. (Mary) 
Self-stigma I do whatever I have to do for whatever work … because I need to work. And, 
like I said…. I'm too young to be treated like an invalid. And I don't want that. 





Research Question 1: The Experience of Chronic Pain  
The most common theme was managing days when chronic pain was less intense and 
days when the chronic pain was more severe. The goal was to find a balance where the 
chronic pain was still present, but participants could still function. Participants used various 
idiopathic strategies to achieve this goal. 
Good Pain Days 
These days were sometimes the result of adequate pain management strategies. Other 
times, relief appeared to be a matter of luck. Dina said, 
A good day would be I wake up and it feels good and … I'm very motivated…. you 
just have an outlook where you're ready to go. You're not exhausted…. you just feel 
light. In the mornings, [if] you wake up and there's that pain or that constant nagging 
discomfort, then you're almost defeated before you start…. 
Ada said, 
A typical day now is studying in the morning. My first few hours in the morning are 
always spent studying. I do gym after that. I finish any errands I have after that. 
Either I come back to studying or I've been looking for work recently. I started 
volunteering teaching, right now, teaching adults.  
Rita said, 
I'm sitting at the computer working, which I was this morning. So, I took an 
Excedrin. I take an Excedrin every day. There's … never a day when I don't take an 
Excedrin. Because it does help take the edge off. But when it's really bad, I might 




while. And that helps, or to put heat on it. And I put heat on sometimes. Other than 
that, there's nothing different. I do the same things, whether I'm in pain or not. 
Difficult Pain Days 
Sometimes, difficult days resulted from anxiousness, over-doing a task, or meeting 
otherwise everyday demands of life. Other times, there was no predicting or explaining days 
with more pain. Mada said, 
So, I did go through to the hospital. I was hospitalized for two weeks because I have 
jaundice and chronic hepatitis…. So, I got out of the hospital and everything was fine. 
I lived my life normally again. And then in 2013 … the pain started. And … I had to 
go through … six years until 2020, when I had my liver transplant. 
Ada said, 
When somebody is in pain, it can be difficult … to get doctors that understand you…. 
[And] then I didn't want to go. I told my mom, I give up on going to doctors…. So … 
[it’s] the same way a woman meets the man of her dreams. It was the doctor of my 
dreams. He understood exactly what I was talking about. 
Research Question 1, Subquestion 1a: Access to Treatment 
While the experience of going to the doctor varied by the primary pain strategy used, 
many participants spoke of hiding pain from doctors. Also, regardless of pain strategy, pain 
management often had multiple doctors, and it sometimes did not improve treatment. 
Multiple Doctors and Uneven Outcomes 
Even when a participant could find a doctor who would treat their chronic pain, this 




It's a local physician. And so, I'm sure that he would order pain medication for me, but 
I have not asked for it. He knows what I have. He's gotten all the reports from all the 
physicians…. He's a GP, so he's not going to know anything to do with it. 
Bill said, 
I am probably supposed to get a yearly checkup, at least for the fire department's sake 
and haven't gotten one yet. It's a whole time issue. And I'm kind of afraid of what 
they will say about my knees. And that [I] might not be able to work anymore. And I 
know that I'm very capable of working. I'd just go out and do it. So, I'm a little 
concerned what they might say [something] about my knees. I really never got up to 
getting a physical done. 
Justin said, 
[Interviewer, “And how do you feel when you leave the office of a typical doctor 
visit? Do you feel like something has happened or you've been helped?”] Not really, 
because … they tend to just tell me … [to] take pain meds [OTC] and stuff like that 
… Not too much physical activity. And because that's something that I already know 
and already do.  
Jean said, 
I'm not a complainer. You know, I may go in and speak of this or that. But I just feel 
like they've always said there really was nothing that … they could do. So, I don't 
even bother with it anymore. I don't even bother discussing it. I just figured, what are 
they going to tell me? Ice and take pills … and I already know that. So why waste 





So, I went from being seen and cared for very meticulously prior to my transplant and 
after my transplant. And then I was put on to a transplant kidney specialist that's not 
part of the surgical team…. And I see him for literally five minutes…. “Your blood 
test looks great… your meds look fine. Let's get you set up for a rheumatologist.” 
Well, I've seen rheumatologists for the last couple of years. And I keep getting the 
blood tests. It's not that. So. he can't figure it out because if it's not the kidney 
problem, it's not the meds I'm on from the kidneys. He doesn't know what to do for 
me. And only knows what to do is point me towards a rheumatologist. [Finally, the 
doctor says] “Do you have any questions?” [I replied] “I have joint pain, or I have 
this pain … I need to take care of it to see what it is.” And he kind of scratches the 
head…  “I don't know what to do for you, it's a pain thing. I'm not the pain guy….” 
Research Question 1, Subquestion 1b: Experience with Pain Management.  
The success of a given management strategy also depended on idiosyncratic factors 
plus the severity of the pain. If the chronic pain was too severe, most pain management 
strategies failed. All participants reported incidents where there might have been an 
improvement in the managing of chronic pain. This outcome might indicate possible 
undertreatment, though no participant used that term. The next chapter will address 
undertreatment in more detail.  
As participants experienced more anxiety, they seemed to experience more pain. All 
doctors appeared to use the biomedical model. On their initiative, some participants found 




Very Severe Pain 
Severe pain days were often commented upon by all participants. If the pain was too 
severe, participants tended to stay home when they could. Dina said, 
 A bad day? [I] just get my coffee. Sit down. Turn on the news. Maybe just … take 
some Tylenol and putter around my house. I feel like doing something, but I don't feel 
like doing something. My mind says I do, but my body says no … I'll just sit back 
down …  and watch … TV … [then] get up and … pace in the house. Like I'm 
uneasy or antsy. I'm bored. But you don't know what to do with yourself. 
Peter said, 
If it were like eight out of ten, it would probably mean that I'm going to have 
difficulty getting to the kitchen. I would stay in bed longer. I would probably be just 
worrying, at that point, and not really able to … do much about my pain. 
Ada said, 
Poor pain days is when I tried to go to the gym, and I can't. And if I push myself, I 
can only do very, very basics. Maybe just a little bit of walking. It's [when] I have to 
take something for the pain. I would have to put … cold and hot compression on my 
neck. It depends on how bad the pain is. But at times it's so bad, I mean, I cannot even 
hear anything. That's how bad the pain gets. And other times… I just have to do 




Anxiety and Pain 
Anxiety reportedly increased pain. For some, decreasing anxiety was a psychological 
intervention in pain management. The next chapter will discuss anxiety management and its 
implications for pain treatment. Caity said, 
I was a constant, stressed-out mess. And I have subsequently learned that complicates 
every physical thing I have.… And I was sad about that … but my pain has always 
been worse when I'm discouraged. If I feel like somebody is listening to me, and that 
there is light, not necessarily at the end of the tunnel, but there's something I can do. 
There is some responsibility I can take to make this better … then I can endure it.  
Peter said, 
Oh … my physical therapist told me. It was a mixture of the nerves, the physical 
nerves firing a whole lot when stimulated. And that my pain was also making me 
more anxious. And anxiety adds to the perception of my pain. So, it's more like I was 
used to feeling pain for so long that like even resting my leg at an angle was enough 
to stimulate a pain response…. I was concerned about my anxiety.  
Nija said, “But … the one thing I have noticed that stress a lot adds [to] the pain. So that's 
one thing I'm sure of. And I was kind of surprised when the doctor told me that.” 
Biomedical Treatment with Biopsychosocial Elements 
Participants who received medical treatments for chronic pain had doctors who used 
the biomedical model. Yet, some participants found elements of the biopsychosocial model 
to manage pain. Ada said, 




to do as much meditation as I can at the house, while I'm at home or outside. Once in 
a while, I go on a retreat for a couple of days, just to … regenerate your inner drive, 
the mind, the body and all of that. All those have helped. 
Peter said, 
I was having a lot of pain. I was still trying to … do things that help me like remain 
satisfied with my life. Like I was meditating daily and that seemed to help. I was still 
doing pretty well in school. I think I actually was very involved with school because 
it was a good distraction from my anxiety about like reinjury and pain.  
Caity said, 
I really am very happy. And so now I'm back hiking and doing yoga and kayaking 
when the weather is conducive. And … [I] got rid of the boyfriend that didn't like a 
handicapped woman in his life. And I also attribute a lot to counseling because I was 
just buckling under the stress. And that was a big help. I did that for maybe two and a 
half years in the middle of the back saga. 
Research Question 2: Meaning of Stigma 
The experience of stigma was also idiosyncratic but had many similarities. 
Social Identity and Liminality 
Whenever possible, participants avoided talking about their pain with people who 
might not understand or judge them. Other times, trusted people provided social supports that 
enhanced the ability of the participant to manage pain. Dina said,  
[Interviewer: So how do you feel about the fact you have to hide your pain from 




Debbie Downer. So … in the moments that I'm with people … not particularly my 
family or sisters, but say my friends, just … being around them and hearing their 
goings-on and feeling a part of that … is actually uplifting for me. So … I don't talk 
about my pain. If they ask me … I'm just very vague about it. Most of the time … I 
want the positive effect of their company. 
Bill said, 
Frustrating. I grew up in a house where my dad was in the army. My mom was a nurse 
and they made light of everything like, “Oh, it's not really that bad….” I've had several 
injuries as a kid. So, I … [just] shrug it off …. So, yeah, it's frustrating.  
Sally said, 
They didn't notice [my pain] and I don't complain about it … I mentioned it a couple 
times to some friends, and [now] I just don't bring it up…. It's not a topic of 
conversation. Some people occasionally … know I have … pain. They'll ask me 
about it. But, normally, it doesn't come up … sometimes my family, like my older 
sister, may ask me. “How is it?” And I’ll say, “Well, it's just there. I mean, it's not any 
worse, any better.” You just handle it.  
Rita said, 
I don't think they realize I'm in pain. I said something to my son a couple of weeks 
ago. I don't think they realize I'm in pain because I don't talk about it or complain 
about it … when it gets really bad, I'll [sometimes] complain about it….  
George said, 




they're not pain specialists…. But a lot of times they just said it was not a real thing. 
It's in my head. Or I was a hypochondriac. Or, you know, we can't find any physical 
thing that caused this pain. So, it's not a real thing…. 
Jean said, 
Well, just very old, very helpless, very useless, very not contributing. When I was on 
disability and then I wasn't working, I felt horrible. Because … I wasn't bringing any 
money in…. when I stopped doing the work that I was used to, and wasn't making as 
much, I just felt … just so limited. What can I do now? You know, I used to be able 
to do anything. And now my options are, I've got to pick and choose whatever. And 
I'm not good at that kind of work. The work I'm good at, I can't do now. So, what am 
I gonna do? So, kind of scared. 
Evidence of Resilience 
There was also evidence of resilience in most participants. Resilience was apparent 
when participants reframed their pain as an experience where they had functional or 
psychological control. This evidence was more noticeable when participants faced with 
everyday stressors or unexpected events or changes. Rita said, 
One time, a couple of years ago, when I was having that hip issue and I was going to 
go horseback riding. And my one relatives … who tends to be negative, said, “Don't 
go. Maybe you shouldn't go.” And I said, “No way. I'm going to go. I don't care. It 
hurts anyway. I might as well go and have fun.” Which I did…. I had a blast and it 
was fine. As a matter of fact, for some reason … doing that horseback riding that day 




fact of sitting in the saddle. 
Mada said, 
I'm a person that never actually talks about pain. They [my family] used to feel that 
without me saying [it] … And they used to know whenever I'm in pain, [when] I need 
to be alone. [Or] I need to speak. They were not [the] kind of people that [say], “Oh, 
my God, why are you calling us? Why aren't you answering, blah, blah, blah?”  No, 
they always were there. They never left my side … And my mother played a very big 
role, and all my family did. But my mom was number one.  
Sally said, 
I've taken ibuprofen. I've taken Excedrin. Those are the two main pain medications. 
They don't really affect it. But I think that's more psychological, for me to be able to 
take something. But sitting for long periods of time and driving really was the worst. 
And I was on the road a lot for the last three years. So that was really the worst time. 
And now that I'm back in the office [and] sitting is really doing it to me. I have no 
pain at night … sometimes I don't notice it as much as other times. Sometimes it's 
really difficult to handle. But … there's nothing you can do about it. So, I just handle 
it.  
Research Question 2 Subquestion 2a: Stigma Experienced During the Treatment 
Process 
Stigma from Medical Professionals 
All participants reported the experience of stigma in a variety of ways, though not 




“Are you visiting your psychiatrist recently?” Because I have a psychiatrist. “No … 
I'm just telling you that I'm in pain, and you guys have to do something about it….” 
Because I felt like they were taking it in such an easy way.  
Justin said, “There is one doctor that I went to and he had, jokingly …said, ‘You might just 
be faking it ....’ But … I came there in real pain. I don't need you to joke about it….” 
Research Question 2 Subquestion 2b: Stigma From Family, Social Supports, and Self-
Stigma.  
Many participants also expressed being shamed by others, mostly from people they 
knew. Even when participants attempted to hide their pain from strangers and other 
acquaintances, stigma from family and friends was evident. Sometimes, though, it appeared 
unintentional. 
Stigma from Family and Friends 
Peter said, 
I was upset and frustrated with how [my father] expressed his emotions. But he wasn't 
making me or forcing me to carry things. I am grateful he stopped when I told them 
how I was not comfortable with helping out. He didn't force me to do things. He just 
wanted me to do [more] things.  
Caity said, 
And I have never, ever forgiven my friends, that I hike with. Because they all trooped 
off [when I was injured and could not walk]. And there were just … two frail people 
[left] who felt sorry for me and just cheered me up. But all my friends just marched 




Mary said, “Of course, that hurts because everyone keeps teasing me about I need to go in 
bubble wrap and stuff. They don’t understand…. I haven’t done any of this stuff on purpose. 
I didn’t have plans to hurt my back in nursing [school]….” Justin said, “There have been 
times during physical activity where I have to take a break because my back hurts. And, you 
know, people are rag on me. But nothing serious because they know that I do have back 
issues.”  
Self-stigma 
When describing their chronic pain experience, self-shaming was common. It often 
took the form of not wanting to be a burden or be labeled as a complainer. Often these 
participants hid their pain whenever possible. Racheal said, “[You are depressed] but you just 
push yourself because … there's no one else to do anything. And you just have to take care of 
him [her husband] and that's all.” 
George said, 
Mentally, not good. Yeah, physically, obviously still hurting, but mentally it was very 
frustrating. I caused a few ruckuses every now and then. Like I'd go up the chain [of 
command]. But I felt, I don't want to use the word helplessness and bad, but it was 
helpless…. I can't do anything about it. I just got to trudge on and just deal with it. 
But it was to the point where mentally I felt drained. I felt lonely about it. You know, 
my wife, she couldn't do anything. She just said, well, let's go see a doc cause she's 
not a pain person. She just knows what I was doing every morning. But it felt like this 
can't be it. Someone's got to know about this stuff. Because I wasn't the only one…. 




something like this with no answers. 
Jean said, 
Well ... one day … they'll say, oh, your back's bothering you today, isn't it? And … I 
just brush it off. I don't want people feeling sorry for me. And I don't want to be 
treated any differently. Especially at my work. I'm not a complainer or anything. I do 
whatever I have to do for whatever work … because I need to work. And, like I said 
… I'm too young to be treated like an invalid. And I don't want that. So, I just kind of 
pretend I'm okay most of the time. 
Evidence of Trustworthiness 
Credibility 
The recommendations of Saldaña (2016) guided the establishment of credibility. 
There was prolonged contact with the data. I did four separate analyses: a) the review of the 
computer-generated transcripts against their audio recording, b) a structural analysis of the 
transcripts to organize the pain stories into chronological narratives, c) a computer analysis of 
the transcripts to identify experiences in common; d) a member check using a synopsis of 
each pain story to insure accuracy and record any developments, and (e) identification of 
counterexamples not anticipated by the research questions. 
By including two extra participants in the study than planned, I found evidence of 
saturation. The last four interviews reported no new experiences. Also, participants were able 
to be grouped according to their primary pain management strategy. Despite any differences, 




For the member check, each pain story was re-written in the third person. I password 
protected member check files and then emailed to each participant with 2-step certification 
over the phone to unlock the file. Most participants, however, were unable to open this file. 
In a second attempt, I sent printed synopses to each participant prepared using COVID-19 
safe protocols. The responses to these synopses included only minor changes that did not 
change any themes. Three participants did not respond to the second member check, but the 
other 14 members usually stated that the synopses accurately described their chronic pain 
experience. 
Transferability 
The commonality of the experiences of the participants despite having different 
diagnoses, ages, pain management strategies, and circumstances was evidence of 
transferability. For instance, most participants had to start each day while still in bed. During 
this time, they planned how to approach the expected demands of the day, plus how they 
might pace themselves to manage their pain and still achieve their daily goals. 
Dependability  
In my proposal, there were concerns that the contentious history of caring for my wife 
might have created biases for reaching conclusions. I followed Roulston and Shelton (2015) 
six suggestions for managing bias in a qualitative analysis, which included: (a) 
acknowledging interests of the researcher and how it might influence data analysis, (b) 
reflecting on how closely the data stayed within the range of the research questions, (c) 




data surprised the researcher, and (e) explaining how the conceptualizations of the researcher 
changed the throughout the study.  
All participants met the following criteria: (a) were 18-years-old or more; (b) were 
able to express the details of their condition; (c) were able to consent to the study; (d) 
responded to a formal invitation to participate from a referral source or who approached me 
and volunteered; (e) had experienced their pain for three months or longer; and (f) 
experienced persistent, chronic pain daily or regularly. These criteria ensured that the 
participant had adequate experience with current medical treatments. It also confirmed that 
the participants had experiences with ongoing pain limitations.   
Participants were not limited to those unhappy with either their doctor or their 
treatment regimen. Neither were those participants excluded. There was a purposeful attempt 
to solicit participants from minority groups. Monsivais (2013) stated that bias was evident in 
chronic pain management. He questioned whether minorities had increased difficulty seeking 
treatment for chronic pain.  
Confirmability 
The reflexivity evident in the multiple exchanges between the researcher and all 
participants indicated confirmability. In these exchanges, participants sometimes reflected on 
how their participation in the study changed their lives.  As Rita put it, 
[K]nowing I was going to be doing this interview about pain, made me realize … I 
get cranky because … I'm so tired. All I want to do is lay down because my neck is 
hurting, or my back is hurting. And … if the kids … need things … I want to be able 




Evidence of Ethical Procedures 
All data were kept confidential. Identifying information was stripped from all 
narratives. I was not in a power relationship with any possible participant because I was 
retired from full-time employment. Some of the participants who responded to the invitation 
came from family, friends, and acquaintances in persistent pain. All participants responded to 
a referral source request or approached me and volunteered. I kept interview data 
confidential, even from other acquaintances and family members, unless I had written 
permission. Each narrative had an identifying number and a pseudonym. I stored the personal 
information on my home computer or in a locked box file for paper records. 
Summary and Transition 
This study interviewed 17 participants regarding their experience of chronic pain. All 
participants interviewed were able to describe their experience with pain and their access to 
treatment. The most common themes revolved around managing pain with different 
strategies daily to retain/aspire to a quality of life worth living. Most participants experienced 
stigma in various forms. Stigma came from people they knew, mostly medical professionals, 
family, and friends. 
For participants not using addictive drugs, a brief discussion on addiction 
occasionally occurred during medical meetings. For participants who used opioids, however, 
these meetings were challenging and often produced anxiety. These challenges remained 
ongoing. 
Common themes were identified through the structure of the interviews and how 




quotations. The themes showed that pain management was idiosyncratic to the individual, 
though there were many similar pain experiences. The data demonstrated trustworthiness. 
There were both common themes and unexpected experiences that were not anticipated by 
the research questions. The data achieved saturation because the last four participants 
interviewed added no new experiences to the data. Reflexivity was evident because of the 
multiple exchanges between the researcher and all participants. Finally, there was evidence 
of transferability because all participants had no difficulty answering the questions and 
creating a narrative with a beginning, middle, and end. 
Chapter 5 presents how the study’s results compare to existing research and how the 
results might point to a possible synthesis in pain conceptualization. I describe how these 
results point to the need for psychological interventions to help people in pain, regardless of 
severity or diagnosis. This chapter also discusses other implications of the findings, and the 





Chapter 5: Discussion, Conclusions, and Recommendations 
In this qualitative study I explored the complex nature of chronic pain through the 
narratives of adults who experienced it for 3 months or more. The primary focus was to 
investigate whether exploring the voice of pain sufferers would deepen the understanding of 
the experience of chronic pain and improve treatment (see Eaves, 2015; Rajagopal, 2011; 
Tsao, 2012).  
Key Findings 
I conducted a narrative analysis, and 17 participants were interviewed. The results 
were generated from both structural and thematic analyses. The structural analysis revealed 
distinct groups (pain-free; nonopioids to manage pain; opioids to manage pain), and the 
thematic analysis identified 12 themes to describe the nature of their pain experience and 
how they experienced stigma both in treatment and in their social interactions with family, 
friends, and community. These findings supported the need for a biopsychosocial approach to 
chronic pain treatment. The results also seem to align with the approach that chronic pain 
treatment is better addressed as a separate disease rather than a symptom of an underlying 
problem. Finally, the results showed that insights can arise from the narratives of people 
experiencing chronic pain. 
 There were dramatic experiential differences among participants who used 
opioids or other potentially addictive medications to manage their pain. Yet, there 





 All participants discussed needing to balance the ebb and flow of chronic pain. 
Their goal was to find a balance where their chronic pain was still present, but the 
participants could function. Participants sometimes received medical help in 
developing their pain management strategies. More often, the participants 
developed unique pain management strategies with only occasional guidance 
from medical professionals. The resulting pain strategies were often idiosyncratic.  
 All participants responded affirmatively to the questions about good days and bad 
days, but the reasons behind their comments varied considerably.  
 Most participants reported that anxiety increased their pain. 
 Most participants had a story of experiencing stigma when doctors dismissed their 
pain or experienced stigma from medical professionals. Other sources of stigma 
included family, friends, and casually encountered strangers. Participants also 
reported feeling self-ashamed about their pain and their attempts to participate in 
everyday life.   
 There were instances of discrepant cases, where two of the 17 participants were 
pain-free at the time of the interview. In one case, this was due to extensive 
physical therapy. In the second example, pain relief came through faith healing. 
Interpretation of the Findings 
The results reflected many findings in the research on chronic pain. Overall, the wide 
variety of treatments may reflect the lack of consensus on the definition of chronic pain and 
treatment found in the pain research (Bourke, 2014; Wailoo, 2004). A comprehensive listing 




Some of the experiences of participants seemed to fit into three categories: (a) pain-
free participants, (b) those who did not use addictive medications to manage pain, and (c) 
participants who used potentially addictive medicines regularly. Yet, all groups had 
numerous experiences in common. For example, reaching out to their physicians and medical 
professionals often resulted in recommendations for medications, surgery, or physical 
therapy (Peppin et al., 2015). As described earlier in Chapter 2, the biomedical model has a 
minimal repertoire for treating chronic pain. Participants reported feeling frustrated and 
sometimes despondent (Jurecic, 2012). For example, when an on-call doctor suggested Ben 
reduce his medication because he had been on it too long, Ben responded, “You know I'm a 
laborer. I've worked hard all my life. I still have one leg longer than the other. And I'm in 
constant pain.” Nonetheless, the doctor continued to dismiss his pain. 
Most participants had little more than a casual discussion with doctors regarding 
addiction. The interaction was more confrontational if participants took a potentially 
addictive drug, or their doctor concluded they wanted one. Commonly it was opioids, but it 
was also benzodiazepines or other kinds of anxiolytics. Such participants felt they had to 
prove a negative (i.e., demonstrate that they were not abusing medications). After they found 
a doctor willing to prescribe their medications, there were ongoing concerns that a new 
doctor would refuse to prescribe the potentially addictive drug. Yet, no participant who used 
potentially addictive medicines to control pain appeared to be abusing those medications. 
George reported, “But a lot of times they [the doctors] just said it was not a real thing … I 
was a hypochondriac. Or, you know, we can't find any physical thing that caused this pain.” 




did not always lead to addiction, and opioids can be useful in managing long-term pain 
(Chapman et al., 2010; Gourlay et al., 2005; Heit, 2001; Kumar et al., 2015; Ljungvall et al., 
2020; Rajagopal, 2011; Vowles et al., 2015; Wilbers, 2015) 
Balancing the Ebb and Flow of Chronic Pain  
While every participant reported experiencing an ebb and flow of chronic pain, they 
reported various approaches to finding a balance. The data showed that nearly all 17 
participants felt that their daily activities influenced their chronic pain (see Appendix E). 
OTC treatments were popular supplemental pain management approaches and were often 
used in combination with other therapies. Also, OTC medications were preferred and used 
more frequently than prescribed medicines (Eaves, 2015). This preference could be because 
opioids were not available to most participants. Yet, 14 of the 17 participants felt that using 
opioids would lead to addiction and said they would refuse those medications if offered 
(Bruehl et al., 2015).  
Biopsychosocial strategies (Engel, 1980) were used as supplemental pain 
management strategies and included: (a) limiting or modifying daily tasks (Jensen and Turk, 
2014); (b) regular exercise (Slade et al., 2009); and (c) cognitive-behavioral techniques 
including mindfulness, meditation, or psychological counseling (Sheedy et al., 2017; 
Sturgeon & Zautra, 2016). Often, the participants developed their own pain management 
strategies with only occasional guidance from medical professionals. Most participants 




Anxiety and Pain 
Increased pain seemed most significant when anxiety negatively affected social 
identity (Major et al., 1998). It was particularly evident when participants reported 
embarrassment at not maintaining their previous level of functioning. As they lost friends, 
jobs, and spouses, their self-esteem suffered. When perceptions became internalized, 
participants often seemed to blame themselves for their predicament (Monsivais, 2013). So, 
from a psychological point of view, finding a way to prevent self-shaming and reduce 
anxiety, in general, seemed to be a point of possible psychological intervention to improve 
pain management. 
Over time, anxiety had a cumulative effect on pain (Ljungvall et al., 2020; Palmeri, 
2016; Wong et al., 2015). As this cycle progressed, chronic pain sometimes increased beyond 
what medical professionals would expect (Kaufman & Baucom, 2014). Anxiety was often 
evident in the reports of pain by participants. These reports could explain the findings that 
doctors often felt that patients exaggerate their chronic pain feelings (Staton et al., 2007). 





Figure 2  
 



















Note. This figure graphically illustrates the cumulative effect of anxiety, pain and suffering. 
As chronic pain continues, it creates anxiety, and this increased overall suffering. If left 
unattended, anxiety can increase overall suffering, leading to further interventions for 
adequate pain management. 
 
Undertreatment Was Evident 
All participants struggled with pain management. In the literature, this is identified as 
undertreatment, and it was a frequent topic in the peer-reviewed literature on pain (Abdallah 
& Geha, 2017; Arnstein & Herr, 2017; Björk et al., 2016; Breivik et al., 2006; Clauw et al., 
2019; de C Williams, 2016; Hiller & Suominen, 2017; Kehlet et al., 2006; Nordmann et al., 
2017; Paydar et al., 2016; Platts-Mills et al., 2016; Peppin et al., 2015; Rajagopal, 2011; 
Trentin et al., 2001; Wailoo, 2014). Ten participants in this study explored biopsychosocial 
techniques for pain management (e.g., yoga, exercise, meditation, diet), yet they reported 




participants did not report the need for biopsychosocial strategies (see Gourlay & Heit, 
2009). Nonetheless, their regular reports of severe pain suggested whether a more 
comprehensive, physician-directed approach might improve treatment outcomes. This 
study’s findings concurred with the literature in that many of those participants would refuse 
stronger, potentially addictive medications even if offered (Bruehl et al., 2015). However, 
three participants found opioids and other addictive drugs essential to their functioning (see 
Ljungvall et al., 2020; Rajagopal, 2011). 
Often, when pain could not be relieved, the participant stated they would "push 
through the pain." The success of this strategy depended on pain severity. If the pain was too 
severe, this strategy usually failed. However, almost as often, many participants responded 
with resilience and an openness to better pain management. In this study they reported: (a) 
ignoring the pain and continuing with a planned activity, (b) intentionally lowering their 
anxiety through reframing; (c) seeking counseling; (d) reaching out to family and friends for 
support; (e) changing their physical environment; (f) testing whether they could expand their 
exercise regime even when it might increase their pain; (g) warning supervisors of their 
limitations and asking for an accommodation; (h) challenging any pain medication to see if 
they needed it; (i) getting training and taking college courses to find employment more 
compatible with their limitations; (j) taking time to engage in favorite activities; (k) 
increasing exercise even if it risked short term pain; (l) confronting medical professionals 
when they exhibited bias or stigma; (m) fighting for the right to continue employment after 




mindfulness strategies (see Ambrose & Golightly, 2015; McCracken,1998; Rupp et al., 2004; 
Sheedy et al., 2017; Sturgeon & Zautra, 2016; Wong et al., 2015). 
Four participants hoped their next medical intervention would stop their pain forever. 
The rest of the participants accepted that they might be in pain for the rest of their lives. 
Those participants seemed less hopeful about their future and more resigned to their fate. 
The Experience of Stigma 
Most participants had a story where a doctor dismissed their pain (Coleman, 2011; 
Katz & Rosenbloom, 2015; Macciocchi & Eaton, 1995; Newton et al., 2013; Roese & Olson, 
1996; Waugh et al., 2014). While seeking medical treatment, the reports of stigma did not 
seem to be limited by gender, age group, or geographic location. Other than stigma from 
medical professionals, many participants expressed being shamed by others, mostly from 
people they knew, including self-shaming (Abdallah & Geha, 2017; Armentor, 2017; Hiller 
& Suominen, 2017; Monsivais, 2013; Waugh et al., 2014; Werner et al., 2004; Wilber, 2015). 
Despite these experiences, 8 of the 17 participants expressed faith in their doctor to manage 
their pain. The other nine participants felt that their doctor was no longer helpful or was 
never beneficial in their pain management. Yet, these participants still sought medical 
intervention for other medical problems.  
Theoretical Analysis of Findings 
The methods and analysis were guided by social identity theory, attribution theory, 
and the construct of stigma. The results of the study also revealed the relevance of barriers to 




In social identity theory, the experience of liminality (as described in Chapter 2), was 
defined as the consequences associated with changes in a person’s social role that resulted in 
feelings of being in limbo. Expressions of hopelessness (e.g., regret at losing a vital 
employment role or internalizing experienced stigma), were examples of  liminality (Jackson, 
2005). In addition, hiding their real feeling of pain to protect a former social role could be 
considered a part of the liminality experience (Monsivais, 2013). Other statements included: 
a) feelings of helpless; b) being frustrated with the limitations of pain; c) feeling left out of 
recreational and routine activities; d) hiding feelings of pain from friends to prevent pity; e) 
being fearful of the future because of their chronic pain; f) saying few people understood or 
empathized with their pain complaints; g) being worried about limited employment 
opportunities; and h) expressing fears of being labeled an addict (Cacioppo et al., 2015; 
Carlsen & Nyborg, 2017; Hawkley & Capitanio, 2015; Major et al., 1998; Monsivais, 2013; 
Oliveira et al., 2015; Sturgeon & Zautra. 2016) The uncertainty produced by stigma and 
chronic pain exemplifies how people move through the liminal state in negotiating their 
social identity and seeking help (Dauphin et al., 2020). 
Attribution theory was useful in understanding why patients and doctors disagreed on 
the severity and causes of persistent pain (Carlsen & Nyborg, 2017; Katz & Rosenbloom, 
2015; Newton et al., 2013). As described in Chapter 2, attribution theory is useful for 
understanding the circumstances under which people attribute a cause to self or something 
else. In this research, patients described how doctors refused to attribute their pain experience 
to a condition or symptom when the sources of the pain could not be detected by biomedical 




weakness, or seeking addictive drugs. Attribution theory also explains why participants hid 
their pain from doctors and medical professionals (Jackson, 2005; Monsivais, 2013; Waugh 
et al., 2014; Werner et al., 2004; Wilbers, 2015).  
The construct of stigma was explored from multiple perspectives. The sources of 
stigma were varied and reflected the sources of stigma found in the research (Bell & Salmon, 
2009). Participants report the experience of stigma from: (a) doctors (e.g., that they were 
complainers or seeking more drugs); (b) from family and friends (being ostracized from 
family and friends for “not keeping up” or being limited from activities by pain); and (c) self-
stigma (feelings of being punished, feeling hopeless and unworthy of support, feeling 
responsible for their pain). These examples of stigma are consistent with other studies 
(Dauphin et al., 2020; Jackson, 2005; Major et al., 1998; Werner et al., 2004). 
Emergent Ecological Model of the Barriers to Pain Relief 
A surprising and consistent set of experiences that were described by participants 
were the barriers encountered while accessing treatment and support. These barriers 
included: (a) governmental and legal barriers to pain relief such as laws that prevent doctors 
from making an independent decision on pain treatment; (b) institutional and administrative 
policies that interfered with doctors and patients relationships, including a lack of insurance 
reimbursement when pain relief programs were available; (c) interpersonal barriers including 
biases encountered during the ordinary course of social interactions with friends and families; 
and (d) internal barriers including personal values, self-shaming, and the inability to accept 
the limitations imposed on the participants by their chronic pain (Littlejohn & Guymer, 




Figure 3  
 
The Levels of Bias that Create Stigma and Other Barriers to Pain Relief 
 
 
Note. Adapted from “Five Mind-Blowing Realities About Race (That White People May Not 
Know).” By M. Lietz, 2018, August 27, Emmanuel Gospel Center, 
https://www.egc.org/blog-2/2018/5/23/3u8bsicsasybnnco5bea7vculw6m9s 
 
The Need for a Biopsychosocial Approach to Pain Management 
On the biomedical side, Carlsen and Nyborg (2017) said that these barriers often 
force doctors into restricting access and treatment, information, and alternative services 
outside of the biomedical model. The authors also noted that the gatekeeper's role often 
conflicted with the ability to be a healer and sometimes left their patients angry and confused. 




biomedical tradition than evidenced-based practices more consistent with a biopsychosocial 
model. It was noted that in this study, while all participants received standard biomedical 
treatment when they sought help, many tried to improve on that treatment by searching out 
biopsychosocial therapies on their own. The result was a panoply of different outcomes and 
idiosyncratic solutions to the management of their chronic pain.  
Limitations of the Study 
This study provided a snapshot of the experience of chronic pain for participants who 
were in chronic pain for three months or more. Credibility was established using two kinds of 
data analyses, member checks, and identification of discrepant cases. There was also 
evidence of saturation because the last four interviews did not contain any reports of new 
experiences. 
Efforts to enhance transferability allowed readers and future researchers to understand 
and use the results to do further research (Shenton, 2004). Methodological details of data 
collection and analysis followed well respected qualitative procedures (Riesman, 2009).  
Dependability was evident because my interests and potential biases were stated. The 
data stayed within the range of the research questions. Participants met all selection criteria. 
These criteria ensured that the participant had adequate experience with current medical 
treatments and experiences with ongoing pain limitations. Participants were not limited to 
those unhappy with either their doctor or their treatment regimen. There was no attempt to 
determine what would happen to these individuals over time.  
Confirmability was evident in the reflexivity due to the multiple exchanges between 




how their participation in the study changed their lives. My analysis did not differentiate the 
person who is abusing an addictive medication from those who require addictive medicines 
to control their pain.  
Recommendations 
Evaluating the sequelae and effectiveness of non-pharmacological chronic pain 
treatments presents several problems (Clauw, 2019). Such future studies would be especially 
complicated if they relied solely on evidence from randomized controlled trials. Shadish 
(2011) stated the concerns with RCT studies when evaluating observational data include: (a) 
ethical considerations of waitlists and no-treatment controls, (b) the divergent outcomes of 
subjects who have varying diagnoses and differing levels of pain severity, (c) the lack of 
consistency in the treatment strategies used with observational data, (d) the lack of consensus 
on desired outcomes and the inability to measure those outcomes objectively, and (f) the 
difficulty of controlling research bias. 
There is also limited value to relying on solely qualitative studies on the chronic pain 
experience to compare any pain management method of effectiveness. Noyes et al. (2017) 
proposed qualitative evidence synthesis as a supplement to deciding the comparative value of 
any pain management intervention. However, the authors further suggested that this method 
may not be adequate to make such a decision without using a quantitative approach. 
Instead of relying on RCT studies and the limitations of qualitative meta-analysis for 
evidence of chronic pain effectiveness, future researchers could use propensity scores. Guo 
and Fraser (2014) stated that propensity scores are a second-best choice when RCT trials are 




Due to the lack of objective measures in determining pain, the idiosyncratic nature of chronic 
pain strategies, the varying diagnoses of pain sources, and the likelihood of bias from 
multiple sources, propensity scores may prove a better research strategy (Devilly & 
McFarlane, 2009). There is considerable research on chronic pain using this kind of analysis 
(e.g., Teh et al., 2010). 
As previously mentioned, this study was a snapshot of the experience of chronic pain 
to date. Of the participants interviewed, 15 still needed to manage their pain daily. What 
happens to these individuals over time? How effective is their treatment? What are the 
sequelae of the experience of pain management? 
As previously mentioned, one way to study the sequelae of chronic pain management 
is to use propensity scores. It statistically divides subjects into groups and is considered the 
best second choice when RTC designs are not feasible. Such a method can use data readily 
available from anonymous quantitative medical records or other sources. It can also employ 
Quality of Life measures and other accepted measures of pain's known comorbid measures. 
Such scales may result in a more useful measure of pain severity. While any given scale may 
not be a fully effective method of measuring pain, multiple measures might be more helpful. 
Future researchers can use a mixed methods design to combine a qualitative evidence 
synthesis with quantitative data. Such research might provide us with insight into the 
usefulness of non-medical strategies for improved pain management, including online 






In addition to more research, effective change requires further training not usually 
provided to medical professionals. Medical policymakers and legislators are encouraged to 
investigate how the War on Drugs harmed the doctor/patient relationships without effectively 
addressing the opioid epidemic. If protocols to treat pain and addiction become more humane 
and used addictive medications when necessary, it may provide a better alternative to 
refusing medicines in chronic pain patients. The problem of drug addiction has increased 
despite laws trying to control the medical use of these medications. The four decades of 
failure using the criminal justice system and subverting the doctor/patient relationship 
requires exploring other approaches that may have better results. (Maté, 2008)  
Another policy recommendation is to explore how harm management strategies might 
help treat both conditions when people are in chronic pain and abusing addictive medications 
(Gourlay et al., 2005). When addictive pain medications are necessary to manage persistent 
pain, harm reduction programs are another option to treat drug misuse and addiction (Ivsins, 
2019; Maté, 2008). 
There is ample evidence in the data that cognitive behavior therapy, particularly 
contextual behavior therapy, helps to manage pain (Sturgeon & Zautra, 2016; Sheedy et al., 
2017). Sirois and Wood (2017).stated that positive psychology health improved physical pain 
management. The authors also stated that these capabilities are underutilized in the treatment 
of chronic pain. Treede et al. (2019) recommended changes on improving chronic pain 
diagnosis. The author speculated that utilizing new ICD codes might encourage 




While the efforts to provide new diagnostic codes for chronic pain are welcome, they 
are not necessary for insurance reimbursement, and are not widely accepted. As a possible 
alternative, the DSM-5 (2013) has redefined Somatic Symptom Disorders. It now includes 
Psychological Factors Affecting Other Medical Conditions (316, F54). This diagnosis would 
allow insurance reimbursement for the mental health treatment of the psychological effects of 
chronic pain. Helping people cope with the impact of psychological suffering is the primary 
focus of psychologists and other mental health therapists.  
Conclusion 
This study supports the research that inadequate pain treatment springs from several 
sources and include: (a) lack of physician training; particularly in the psychological effects of 
pain; (b) treatment models that focused on procedures and symptoms rather than other 
comorbid factors (i.e., the biomedical model); (c) lack of reimbursement from insurance 
companies for biopsychosocial treatments of pain; and (d) fears of addiction from pain 
medications whose proper use is not fully understood. Outside of the doctor/patient 
relationships, other factors that influence the adequate treatment of pain were biases that 
include: (a) pressures from government regulations and professional organizations; (b) social 
stigmatization of pain patients; (c) systemic bias in the medical research and practice; and (d) 
prejudices that are internalized and promote hopelessness in patients with chronic pain.  
This study also shows that when medical professionals confine their treatment to the 
biomedical model, people who suffer from chronic pain will seek out biopsychosocial pain 




supported using opioids and other addictive medications long-term as safe for some people, 
as some research suggested. 
Finally, this study suggests that the regular inclusion of psychological and other 
adjunctive therapies for treating chronic pain might address the lack of consensus on chronic 
pain treatment. The tools for such inclusion, including how one might obtain insurance 
reimbursement, already exist. However, further study on the sequela of chronic pain 
treatment may be necessary to win wider acceptance. These results support the Joint 
Commission's goal to address the prevalent undertreatment of chronic pain in all clinical 
settings.  
Too often, doctors who want to be healers must take the role of gatekeeper. They 
must defend a system where their treatment decisions are restricted. They must maintain 
patient trust and still explain why their patients must endure pain that too often is 
unnecessary. They must face chronic pain management's complexity and overcome the 
psychological effects of stigma in their patients and their own implicit biases. In the primary 
care office, where most long-term treatment of chronic pain occurs, they must perform this 
difficult task in the time allotted by their practice requirements. A biopsychosocial model's 
necessary treatment may be asking too much of the current medical system as it exists. More 
research will be needed to win acceptance of the benefits of biopsychosocial treatment. These 
benefits include reducing the costs of unrelieved pain, encouraging doctors to be healers 
instead of gatekeepers, and encouraging more patient-centered pain treatments. The medical 
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Appendix A: Referral Packet 
Hello, 
Thank you for considering participation in my study on chronic pain.  You were 
given this invitation because one of the people who agreed to help me find participants felt 
that you might be a good person to interview.  What I hope to hear is your pain story, from 
beginning to present, in your own words.  After that, I will compare what you said to what 
others told me.  I expect to interview 15 people and to look for similarities or differences.  
Anything said to me will be kept confidential, even from the person who gave you the 
invitation. 
The reason this invitation did not come directly from me is because my thesis 
committee felt that my experience with caring from my wife’s chronic pain might negatively 
influence my choice of participants.  By putting another person between me and my 
participant recruitment, they believe it would add trustworthiness to the study.  This is also 
why we will conduct this interview by telephone, by appointment, through United 
Conferencing, a computer conferencing organization.  This organization will record the call, 
transcribe what was said, and send the results to me.  This organization agreed to keep your 
confidentiality.  The results will be stored in locked file on my computer.  All recordings will 
be given a number and any identifying information will be stripped from the narration. 
If you wish to participate, contact me in any of ways listed below.  Also, read the 
consent form and, if you agree and understand it, sign it.  Then send if back in the pre-paid 
envelope provided.  Alternatively, if you have a email signature, I will send you a computer 
version. 
Thank you for considering participation. 
Matthew Vittucci, MS, ABD 








You are invited to take part in a research study on what it is like to be in chronic pain. This is 
because you identified yourself as a person in chronic pain for 3 months or more. This form is part of 
a process called “informed consent” to allow you to understand this study before deciding whether to 
take part. 
 This study is being conducted by Mathew Vittucci, a doctoral student in the clinical 
psychology program at Walden University.  You might already know the researcher in another role, 
but this study is separate from that role. 
 
Background Information: 
The purpose of this study is to compare the experiences of different people in chronic pain without 
judgement.  It is hoped that the study will reveal experiences people with pain have in common.  I am 
looking for how people describe their pain, what they tried to relieve their pain, and how chronic pain 
affected their well-being.  It has been reported in research that people in chronic pain feel that telling 
their pain story without judgement has helped them better cope with their pain. 
 
Procedures: 
If you agree to be in this study: 
 You will be asked to tell your pain story, in a face-to-face interview, from its start until now.   
 Your words will be recorded by an audio recorder and transcribed into a word processing file.  
All identifying information will be stripped from this file and it will be given a unique 
number. 
 This interview should take 60-90 minutes and will be done in an area that is private and 
where you feel comfortable. 
 In a second face-to-face interview, you will be able to see the transcript of your story.  You 
can make corrections, add more information, or even decide the you no longer want to be part 
of the study.  You can also talk about any feelings resulting from being in the study.  I may 
also ask for any background information that will be kept out of the transcript and used for 
anonymous participant profiles (gender, age group, ethnicity, social relations, etc.).  Again, 
identifying information will be kept strictly confidential. 
 If necessary, a third session may be needed to add any new information, make changes you 
feel are necessary, or add to any further experiences that occurred after participating in the 
first two sessions. This information may be done by phone, computer, or in a third face-to-
face interview, depending on your preference. 
 
Here are some possible sample questions.  They will only be used as prompts.  Your pain story 
may be told as you see fit:  
 In your own words, tell me your pain story. When did it begin? 
 Describe for me a typical day with your chronic pain? 
 Did it affect your employment or your employment goals? 
 How did your friends and family respond to your pain? 





Voluntary Nature of the Study: 
This study is voluntary. You are free to accept or turn down the invitation. No one will treat you 
differently if you decide not to be in the study. If you decide to be in the study now, you can still 
change your mind later. You may stop at any time.  
 
Risks and Benefits of Being in the Study: 
This type of study involves some risk due to minor discomforts because the feelings discussed are 
emotional and private. If you choose to share a sensitive topic (i.e., that could trigger emotional 
distress, depression, etc.), and need more help, I provide contact information for further support. 
Being in this study should not pose a risk to your safety or wellbeing.  It is not intended to be a 
replacement for regular counseling or doctor visits.  Yet, as stated above, may people find that telling 
their pain story without judgement, in their own words, helps them understand their experience more 
completely. Often, they are better able to describe it to doctors, family, friends, and acquaintances.  In 
addition, it sometimes helps them identify ways to better cope with their pain. 
 
Payment: 
There is no payment for participation. You may keep, however, a copy of your pain story as 




Reports coming out of this study will not share your identifying information. I will not use your 
personal information for any purpose outside of this research project. Your transcribed story will be 
kept secure by an identifying number in separate files.  Identifying information will be kept in another 
file with a security code to prevent unauthorized access. Data will be kept for a period of at least 5 
years, as required by the university.  
 
Contacts and Questions: 
You may ask any questions you have now. Or, if you have questions later, you may contact me via 
email..  If you want to talk privately about your rights as a participant, you can call the Research 
Participant Advocate at my university at 612-312-1210. Walden University’s approval number for 







Obtaining Your Consent 
 




Printed Name of Participant  
Date of consent  
Participant’s Signature  






 In the course of this study, I may have to contact you for several possible reason.  
This information will be kept in a place that is separate from your Pain Story.  It will be 
destroyed after the study is completed and you have been informed of the results.  A phone 










Best way to contact _________________________________ 
 












Just fill out this form and sign the consent form.  Then send 
this page and the last page of the consent form in the SASE. 
Keep the numbers for the Conference Center handy for the 






Appendix B: Script for the Interview 
As we already discussed, the purpose of this study is to explore, in your own words, 
your pain story. As a reminder, everything you tell me will be kept confidential unless you 
tell me something that would be an imminent danger to you or others. I am recording this 
with an audio recorder to make sure I do not miss anything you said. This recording will be 
kept confidential, and your real name will not be associated with this recording or any other 
document except your informed consent form. Do you understand what I just said? Do you 
agree? 
1. In your own words, tell me your pain story. When did it begin? 
2. What was your life like before your chronic pain began? Can you describe for me 
a typical, ordinary day? 
3. Describe for me a typical day with your chronic pain? 
4. Tell me about your course of treatment. When did you first go to a doctor? What 
was suggested? How did you feel about those suggestions? 
5. Then what happened? Was there a turning point, getting much better or much 
worse, in the management of your pain? Or has your pain been consistent since it 
began. 
a. Were there activities you did more frequently or less frequently? 
b. How did it affect your employment or your employment goals? 
c. How did your friends and family respond to your pain? 




e. How did that make you feel? 
6. What is your day like when the pain is well managed? Describe a typical day of 
good pain management? 
7. What is your day like when the pain is poorly managed? Describe a typical day of 
poor pain management? 
8. Let’s discuss your relationships with doctors. Tell me about your relationship the 
current doctor who prescribes (or would prescribe) your pain medications. 
9. What happens now during a typical doctor visit?  
10. How do you feel when you left that office? 
11. How does that doctor assess your pain? 
12. How does that doctor manage your meds? 
13. What was said? 
14. How did that make you feel? 
15. Describe for me what happened during your worst doctor visit. 
16. How did you feel when you left that office? 
17. How did that doctor assess your pain? 
18. How did that doctor manage your medications? 
19. What was said? 
20. How did that make you feel? 
21. What happened during your best doctor visit? How did you feel when you left that 
office? 




23. How did that doctor assess your pain? 
24. How did that doctor manage your meds? 
25. What was said? 
26. How did that make you feel? 
27. Have you ever had a conversation with any of your doctors about addiction?  
28. What was said? 
29. How did you feel about the conversation? 
30. How did it affect your treatment? 
31. Is there anything else you’d like to tell me about your pain story or your 
experience of pain in general? 
32.  Do you know anyone else who might be interested in telling me their pain story?  
33.  Demographics: Gender _______ Age range______ 
Diagnosis of pain condition: _____________________________________  
Medications used: ______________________________________________ 
City/Region: _____________  






Appendix C: Coding Scheme 
No notes were taken during the interview. Instead, raw data was captured solely by 
use of an audio recorder. The recording was transcribed into a Word file only by me. These 
transcriptions were checked for accuracy and stripped of any identifying information 
unintentionally recorded. The first analysis was a structural analysis and was done by hand 
coding. The second and subsequent coding reviews were done with the help of MAXQDA, a 
qualitative computer program (Saillard, (2011). As stated above, the coding scheme looked 
for: a) similarities; (b) differences; (c) frequency; (e) correspondence; and (f) causation 
(Saldaña, 2016). The resulting data from the second and third analyses related to the research 
questions in the form of themes. Since there were discrepant and unexpected results, and the 
last four interviews contained no new experiences, saturation was reached, and no additional 
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